Gene Symbol | Gene ID | Gene Info |
---|---|---|
SP100
|
ENSG00000067066.12 | SP100 nuclear antigen |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr2_231304576_231304752 | SP100 | 22486 | 0.209349 | 0.94 | 1.4e-04 | Click! |
chr2_231283049_231283295 | SP100 | 1701 | 0.447589 | 0.86 | 2.9e-03 | Click! |
chr2_231288983_231289134 | SP100 | 7587 | 0.252285 | 0.85 | 3.3e-03 | Click! |
chr2_231295038_231295189 | SP100 | 13642 | 0.233316 | 0.84 | 4.3e-03 | Click! |
chr2_231274594_231274745 | SP100 | 5988 | 0.260921 | 0.81 | 8.1e-03 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr14_52119548_52120014 | 2.05 |
FRMD6 |
FERM domain containing 6 |
1083 |
0.54 |
chr2_202055015_202055437 | 1.73 |
CASP10 |
caspase 10, apoptosis-related cysteine peptidase |
7308 |
0.16 |
chrX_128905631_128905820 | 1.55 |
SASH3 |
SAM and SH3 domain containing 3 |
8235 |
0.2 |
chr2_54951205_54951706 | 1.52 |
EML6 |
echinoderm microtubule associated protein like 6 |
224 |
0.94 |
chr21_43843966_43844673 | 1.49 |
ENSG00000252619 |
. |
6617 |
0.14 |
chr7_135347682_135347918 | 1.47 |
C7orf73 |
chromosome 7 open reading frame 73 |
531 |
0.73 |
chr15_64388827_64389077 | 1.38 |
SNX1 |
sorting nexin 1 |
727 |
0.57 |
chr2_169965586_169965930 | 1.36 |
AC007556.3 |
|
8505 |
0.23 |
chr17_66294236_66294434 | 1.32 |
ARSG |
arylsulfatase G |
6676 |
0.18 |
chr13_114462597_114462850 | 1.31 |
TMEM255B |
transmembrane protein 255B |
507 |
0.84 |
chr4_90225162_90225490 | 1.28 |
GPRIN3 |
GPRIN family member 3 |
3835 |
0.36 |
chr3_16885562_16885713 | 1.27 |
PLCL2 |
phospholipase C-like 2 |
40815 |
0.19 |
chr3_101798103_101798306 | 1.25 |
ZPLD1 |
zona pellucida-like domain containing 1 |
19884 |
0.27 |
chr17_79318286_79318703 | 1.25 |
TMEM105 |
transmembrane protein 105 |
14020 |
0.13 |
chr7_100290775_100290926 | 1.24 |
GIGYF1 |
GRB10 interacting GYF protein 1 |
3779 |
0.12 |
chr2_68995416_68995584 | 1.21 |
ARHGAP25 |
Rho GTPase activating protein 25 |
6433 |
0.26 |
chr2_197074783_197075137 | 1.19 |
ENSG00000239161 |
. |
5086 |
0.22 |
chr1_67636156_67636590 | 1.18 |
IL23R |
interleukin 23 receptor |
4204 |
0.2 |
chr2_42523029_42523463 | 1.17 |
EML4 |
echinoderm microtubule associated protein like 4 |
5147 |
0.28 |
chr16_85936515_85936777 | 1.14 |
IRF8 |
interferon regulatory factor 8 |
202 |
0.96 |
chr2_106381616_106381767 | 1.14 |
NCK2 |
NCK adaptor protein 2 |
19503 |
0.26 |
chr9_139990830_139991103 | 1.13 |
ENSG00000199411 |
. |
2169 |
0.1 |
chr8_126658824_126659129 | 1.12 |
ENSG00000266452 |
. |
202169 |
0.03 |
chr10_21808108_21808496 | 1.10 |
SKIDA1 |
SKI/DACH domain containing 1 |
1454 |
0.31 |
chr10_6570908_6571130 | 1.09 |
PRKCQ |
protein kinase C, theta |
51182 |
0.18 |
chr10_26737380_26737571 | 1.09 |
APBB1IP |
amyloid beta (A4) precursor protein-binding, family B, member 1 interacting protein |
10121 |
0.27 |
chr11_66887382_66887533 | 1.08 |
KDM2A |
lysine (K)-specific demethylase 2A |
299 |
0.89 |
chr12_92735349_92735601 | 1.08 |
RP11-693J15.4 |
|
79832 |
0.09 |
chr7_50355659_50355810 | 1.08 |
IKZF1 |
IKAROS family zinc finger 1 (Ikaros) |
7416 |
0.3 |
chr5_169719599_169719931 | 1.07 |
LCP2 |
lymphocyte cytosolic protein 2 (SH2 domain containing leukocyte protein of 76kDa) |
5466 |
0.24 |
chr14_73526093_73526244 | 1.06 |
RBM25 |
RNA binding motif protein 25 |
792 |
0.62 |
chr15_75940809_75940992 | 1.06 |
IMP3 |
IMP3, U3 small nucleolar ribonucleoprotein, homolog (yeast) |
147 |
0.84 |
chr2_8443407_8443630 | 1.06 |
AC011747.7 |
|
372378 |
0.01 |
chr21_34673276_34673439 | 1.05 |
IFNAR1 |
interferon (alpha, beta and omega) receptor 1 |
23377 |
0.13 |
chr9_96226998_96227195 | 1.05 |
FAM120AOS |
family with sequence similarity 120A opposite strand |
11222 |
0.14 |
chr11_118110714_118111375 | 1.05 |
MPZL3 |
myelin protein zero-like 3 |
12018 |
0.13 |
chr17_35446704_35446855 | 1.04 |
ACACA |
acetyl-CoA carboxylase alpha |
861 |
0.59 |
chr2_143894376_143894527 | 1.04 |
ARHGAP15 |
Rho GTPase activating protein 15 |
7568 |
0.27 |
chr17_55680493_55680754 | 1.04 |
RP11-118E18.4 |
|
5150 |
0.22 |
chr3_11683522_11683697 | 1.03 |
VGLL4 |
vestigial like 4 (Drosophila) |
1789 |
0.4 |
chr10_93684234_93684699 | 1.03 |
BTAF1 |
BTAF1 RNA polymerase II, B-TFIID transcription factor-associated, 170kDa |
940 |
0.57 |
chr2_36467289_36467617 | 1.03 |
CRIM1 |
cysteine rich transmembrane BMP regulator 1 (chordin-like) |
115616 |
0.07 |
chr5_39163244_39163586 | 1.03 |
FYB |
FYN binding protein |
39714 |
0.18 |
chr7_13950741_13951075 | 1.03 |
ETV1 |
ets variant 1 |
75158 |
0.12 |
chr7_50349438_50349661 | 1.00 |
IKZF1 |
IKAROS family zinc finger 1 (Ikaros) |
1231 |
0.61 |
chr9_123641943_123642094 | 1.00 |
PHF19 |
PHD finger protein 19 |
2412 |
0.27 |
chr9_86596136_86596316 | 0.99 |
RMI1 |
RecQ mediated genome instability 1 |
513 |
0.49 |
chr12_104682142_104682532 | 0.99 |
TXNRD1 |
thioredoxin reductase 1 |
159 |
0.95 |
chr9_95711156_95711443 | 0.99 |
FGD3 |
FYVE, RhoGEF and PH domain containing 3 |
1566 |
0.43 |
chr14_22966516_22966667 | 0.99 |
TRAJ51 |
T cell receptor alpha joining 51 (pseudogene) |
10420 |
0.1 |
chr11_65271971_65272196 | 0.99 |
SCYL1 |
SCY1-like 1 (S. cerevisiae) |
20465 |
0.1 |
chr19_11072349_11072783 | 0.98 |
SMARCA4 |
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 4 |
569 |
0.67 |
chr5_133446562_133446713 | 0.98 |
TCF7 |
transcription factor 7 (T-cell specific, HMG-box) |
3765 |
0.27 |
chr17_66341426_66341824 | 0.98 |
ARSG |
arylsulfatase G |
53966 |
0.11 |
chr2_136886119_136886368 | 0.98 |
CXCR4 |
chemokine (C-X-C motif) receptor 4 |
10508 |
0.28 |
chr6_159463041_159463192 | 0.97 |
TAGAP |
T-cell activation RhoGTPase activating protein |
2934 |
0.26 |
chr4_15006861_15007120 | 0.97 |
CPEB2 |
cytoplasmic polyadenylation element binding protein 2 |
1430 |
0.57 |
chr7_3082037_3082204 | 0.97 |
CARD11 |
caspase recruitment domain family, member 11 |
1359 |
0.51 |
chr3_18766132_18766453 | 0.97 |
ENSG00000228956 |
. |
20944 |
0.29 |
chr8_74659811_74660029 | 0.97 |
STAU2 |
staufen double-stranded RNA binding protein 2 |
12 |
0.99 |
chr2_99325700_99325976 | 0.96 |
MGAT4A |
mannosyl (alpha-1,3-)-glycoprotein beta-1,4-N-acetylglucosaminyltransferase, isozyme A |
17321 |
0.22 |
chr18_18653450_18653601 | 0.95 |
ENSG00000216205 |
. |
11091 |
0.22 |
chr6_15363375_15363526 | 0.95 |
JARID2 |
jumonji, AT rich interactive domain 2 |
37639 |
0.16 |
chr1_29288402_29288553 | 0.95 |
ENSG00000206704 |
. |
23745 |
0.18 |
chr4_114694711_114694862 | 0.94 |
CAMK2D |
calcium/calmodulin-dependent protein kinase II delta |
11703 |
0.31 |
chr2_190166860_190167060 | 0.94 |
ENSG00000266817 |
. |
9527 |
0.28 |
chr1_160610392_160610892 | 0.94 |
SLAMF1 |
signaling lymphocytic activation molecule family member 1 |
6169 |
0.17 |
chr14_69619079_69619292 | 0.93 |
DCAF5 |
DDB1 and CUL4 associated factor 5 |
131 |
0.96 |
chr8_19353312_19353603 | 0.92 |
CSGALNACT1 |
chondroitin sulfate N-acetylgalactosaminyltransferase 1 |
105919 |
0.08 |
chr6_37470020_37470409 | 0.92 |
CCDC167 |
coiled-coil domain containing 167 |
2516 |
0.3 |
chr2_162867793_162867964 | 0.92 |
AC008063.2 |
|
61888 |
0.12 |
chr22_23296822_23296973 | 0.92 |
IGLJ7 |
immunoglobulin lambda joining 7 |
33335 |
0.06 |
chr2_241503761_241504027 | 0.92 |
RNPEPL1 |
arginyl aminopeptidase (aminopeptidase B)-like 1 |
1327 |
0.3 |
chr12_72058645_72058796 | 0.91 |
THAP2 |
THAP domain containing, apoptosis associated protein 2 |
459 |
0.67 |
chrX_123487955_123488106 | 0.91 |
SH2D1A |
SH2 domain containing 1A |
7591 |
0.32 |
chr2_172067040_172067353 | 0.91 |
TLK1 |
tousled-like kinase 1 |
20628 |
0.24 |
chr17_37863541_37863733 | 0.91 |
ERBB2 |
v-erb-b2 avian erythroblastic leukemia viral oncogene homolog 2 |
635 |
0.56 |
chr7_25172152_25172483 | 0.91 |
CYCS |
cytochrome c, somatic |
7337 |
0.26 |
chr5_75701030_75701244 | 0.91 |
IQGAP2 |
IQ motif containing GTPase activating protein 2 |
888 |
0.72 |
chr4_26987241_26987400 | 0.91 |
STIM2 |
stromal interaction molecule 2 |
17302 |
0.29 |
chr2_128784119_128784577 | 0.90 |
SAP130 |
Sin3A-associated protein, 130kDa |
519 |
0.81 |
chr6_42533015_42533216 | 0.90 |
UBR2 |
ubiquitin protein ligase E3 component n-recognin 2 |
1315 |
0.5 |
chr3_27944722_27945009 | 0.90 |
EOMES |
eomesodermin |
180659 |
0.03 |
chr9_100692681_100693016 | 0.89 |
C9orf156 |
chromosome 9 open reading frame 156 |
7996 |
0.15 |
chr6_143999582_143999733 | 0.89 |
PHACTR2 |
phosphatase and actin regulator 2 |
452 |
0.88 |
chr14_71112819_71113028 | 0.89 |
TTC9 |
tetratricopeptide repeat domain 9 |
4419 |
0.24 |
chr14_71115342_71115493 | 0.89 |
TTC9 |
tetratricopeptide repeat domain 9 |
6913 |
0.22 |
chr2_17934011_17934468 | 0.89 |
SMC6 |
structural maintenance of chromosomes 6 |
801 |
0.46 |
chr2_136892276_136892468 | 0.88 |
CXCR4 |
chemokine (C-X-C motif) receptor 4 |
16637 |
0.27 |
chr11_14655776_14656097 | 0.88 |
PSMA1 |
proteasome (prosome, macropain) subunit, alpha type, 1 |
9227 |
0.23 |
chr11_118088083_118088234 | 0.88 |
AMICA1 |
adhesion molecule, interacts with CXADR antigen 1 |
2552 |
0.22 |
chr5_79482379_79482584 | 0.88 |
ENSG00000239159 |
. |
52927 |
0.11 |
chr3_57582054_57582299 | 0.88 |
ARF4 |
ADP-ribosylation factor 4 |
876 |
0.38 |
chr20_57725112_57725442 | 0.88 |
ZNF831 |
zinc finger protein 831 |
40798 |
0.16 |
chr3_59968249_59968400 | 0.88 |
NPCDR1 |
nasopharyngeal carcinoma, down-regulated 1 |
10741 |
0.33 |
chr22_39493815_39494058 | 0.87 |
APOBEC3H |
apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3H |
656 |
0.61 |
chr2_8617325_8617476 | 0.87 |
AC011747.7 |
|
198496 |
0.03 |
chr6_139434683_139434834 | 0.87 |
HECA |
headcase homolog (Drosophila) |
21491 |
0.23 |
chr8_126939819_126940009 | 0.87 |
ENSG00000206695 |
. |
26719 |
0.27 |
chr2_54806316_54807000 | 0.86 |
SPTBN1 |
spectrin, beta, non-erythrocytic 1 |
21127 |
0.18 |
chr17_46801253_46801546 | 0.86 |
PRAC2 |
prostate cancer susceptibility candidate 2 |
345 |
0.5 |
chr15_91644244_91644445 | 0.86 |
SV2B |
synaptic vesicle glycoprotein 2B |
829 |
0.65 |
chr4_78657779_78657930 | 0.86 |
CNOT6L |
CCR4-NOT transcription complex, subunit 6-like |
5772 |
0.27 |
chr1_108385653_108385824 | 0.86 |
ENSG00000265536 |
. |
66860 |
0.12 |
chr10_8104992_8105143 | 0.86 |
GATA3 |
GATA binding protein 3 |
8298 |
0.32 |
chr3_33065058_33065320 | 0.86 |
CCR4 |
chemokine (C-C motif) receptor 4 |
72123 |
0.08 |
chr1_6101250_6101401 | 0.86 |
AL035406.1 |
Uncharacterized protein |
74 |
0.91 |
chr11_73462298_73462449 | 0.86 |
RAB6A |
RAB6A, member RAS oncogene family |
8765 |
0.15 |
chr19_38894202_38894438 | 0.86 |
FAM98C |
family with sequence similarity 98, member C |
511 |
0.6 |
chr21_44313888_44314062 | 0.85 |
NDUFV3 |
NADH dehydrogenase (ubiquinone) flavoprotein 3, 10kDa |
597 |
0.73 |
chr17_62966354_62966778 | 0.85 |
AMZ2P1 |
archaelysin family metallopeptidase 2 pseudogene 1 |
3069 |
0.2 |
chr5_118655848_118656017 | 0.85 |
TNFAIP8 |
tumor necrosis factor, alpha-induced protein 8 |
12938 |
0.19 |
chr10_11267322_11267473 | 0.85 |
RP3-323N1.2 |
|
54058 |
0.13 |
chr13_91998853_91999207 | 0.85 |
ENSG00000215417 |
. |
3829 |
0.34 |
chr3_50646843_50647029 | 0.85 |
CISH |
cytokine inducible SH2-containing protein |
2267 |
0.22 |
chr8_81289205_81289813 | 0.85 |
ENSG00000252884 |
. |
28242 |
0.19 |
chr6_130898031_130898205 | 0.85 |
ENSG00000202438 |
. |
2861 |
0.39 |
chr10_6453030_6453197 | 0.85 |
DKFZP667F0711 |
|
60835 |
0.14 |
chr5_133560624_133561078 | 0.84 |
PPP2CA |
protein phosphatase 2, catalytic subunit, alpha isozyme |
394 |
0.54 |
chr10_135077834_135078056 | 0.84 |
ADAM8 |
ADAM metallopeptidase domain 8 |
12409 |
0.1 |
chr17_33850293_33850718 | 0.84 |
RP11-1094M14.5 |
|
13216 |
0.11 |
chr2_197019655_197020043 | 0.84 |
STK17B |
serine/threonine kinase 17b |
1522 |
0.4 |
chr16_50733857_50734060 | 0.84 |
NOD2 |
nucleotide-binding oligomerization domain containing 2 |
2908 |
0.16 |
chr5_131728590_131728741 | 0.84 |
C5orf56 |
chromosome 5 open reading frame 56 |
17663 |
0.11 |
chr8_23088889_23089040 | 0.84 |
RP11-1149O23.4 |
|
536 |
0.66 |
chr10_30818232_30818501 | 0.84 |
ENSG00000239744 |
. |
26467 |
0.21 |
chr2_84921833_84922112 | 0.84 |
DNAH6 |
dynein, axonemal, heavy chain 6 |
36541 |
0.19 |
chr16_1610009_1610269 | 0.84 |
LA16c-425C2.1 |
|
20170 |
0.08 |
chr13_36050041_36050364 | 0.83 |
MAB21L1 |
mab-21-like 1 (C. elegans) |
630 |
0.47 |
chr14_103273974_103274344 | 0.83 |
ENSG00000238853 |
. |
18231 |
0.16 |
chr2_106355044_106355223 | 0.83 |
NCK2 |
NCK adaptor protein 2 |
6221 |
0.32 |
chr13_41159581_41159833 | 0.83 |
AL133318.1 |
Uncharacterized protein |
48384 |
0.16 |
chr15_68053617_68053829 | 0.83 |
SKOR1 |
SKI family transcriptional corepressor 1 |
58319 |
0.14 |
chr2_42523506_42523974 | 0.83 |
EML4 |
echinoderm microtubule associated protein like 4 |
4653 |
0.29 |
chr13_22637122_22637273 | 0.83 |
ENSG00000244197 |
. |
272521 |
0.02 |
chr6_154476011_154476162 | 0.83 |
OPRM1 |
opioid receptor, mu 1 |
68444 |
0.13 |
chr5_176797295_176797526 | 0.83 |
RGS14 |
regulator of G-protein signaling 14 |
3466 |
0.12 |
chr2_106477499_106477900 | 0.83 |
AC009505.2 |
|
4066 |
0.28 |
chr11_45395872_45396059 | 0.82 |
SYT13 |
synaptotagmin XIII |
88095 |
0.09 |
chr5_52775161_52775379 | 0.82 |
FST |
follistatin |
969 |
0.69 |
chr12_49484155_49484410 | 0.82 |
RP11-386G11.8 |
|
291 |
0.79 |
chr8_91639459_91639696 | 0.82 |
TMEM64 |
transmembrane protein 64 |
18163 |
0.21 |
chr14_81930928_81931079 | 0.82 |
STON2 |
stonin 2 |
28194 |
0.24 |
chr5_138612339_138612490 | 0.82 |
ENSG00000252213 |
. |
545 |
0.43 |
chr15_72978791_72979366 | 0.81 |
BBS4 |
Bardet-Biedl syndrome 4 |
220 |
0.78 |
chr3_42570391_42570707 | 0.81 |
VIPR1-AS1 |
VIPR1 antisense RNA 1 |
3005 |
0.21 |
chrX_39881532_39881925 | 0.81 |
BCOR |
BCL6 corepressor |
40462 |
0.22 |
chr20_57727188_57727345 | 0.81 |
ZNF831 |
zinc finger protein 831 |
38809 |
0.17 |
chr6_83073218_83073369 | 0.81 |
TPBG |
trophoblast glycoprotein |
55 |
0.99 |
chr11_121970753_121970904 | 0.81 |
ENSG00000207971 |
. |
276 |
0.54 |
chr5_156695529_156695722 | 0.81 |
CYFIP2 |
cytoplasmic FMR1 interacting protein 2 |
737 |
0.55 |
chrX_135627974_135628176 | 0.81 |
ENSG00000216060 |
. |
4962 |
0.15 |
chr16_23968756_23969141 | 0.81 |
PRKCB |
protein kinase C, beta |
120404 |
0.06 |
chr6_154499734_154499885 | 0.81 |
IPCEF1 |
interaction protein for cytohesin exchange factors 1 |
68181 |
0.13 |
chr19_35946553_35946707 | 0.80 |
FFAR2 |
free fatty acid receptor 2 |
6013 |
0.12 |
chr3_16360598_16360830 | 0.80 |
RP11-415F23.2 |
|
4768 |
0.19 |
chr11_104941248_104941509 | 0.80 |
CARD16 |
caspase recruitment domain family, member 16 |
25275 |
0.15 |
chr18_13421979_13422167 | 0.80 |
LDLRAD4-AS1 |
LDLRAD4 antisense RNA 1 |
5406 |
0.15 |
chr14_53207062_53207343 | 0.80 |
STYX |
serine/threonine/tyrosine interacting protein |
10302 |
0.15 |
chr17_56248081_56248328 | 0.80 |
OR4D2 |
olfactory receptor, family 4, subfamily D, member 2 |
1187 |
0.39 |
chr3_33100142_33100461 | 0.80 |
GLB1 |
galactosidase, beta 1 |
37983 |
0.13 |
chr6_159434242_159434587 | 0.80 |
RP1-111C20.4 |
|
12564 |
0.17 |
chr11_11158749_11159001 | 0.80 |
RP11-567I13.1 |
|
215098 |
0.02 |
chr16_87491438_87491589 | 0.80 |
ZCCHC14 |
zinc finger, CCHC domain containing 14 |
24773 |
0.15 |
chr3_186635155_186635311 | 0.79 |
ST6GAL1 |
ST6 beta-galactosamide alpha-2,6-sialyltranferase 1 |
13041 |
0.17 |
chr8_71132477_71132643 | 0.79 |
NCOA2 |
nuclear receptor coactivator 2 |
25050 |
0.23 |
chr4_74122655_74122898 | 0.79 |
ANKRD17 |
ankyrin repeat domain 17 |
1263 |
0.41 |
chr20_418602_419173 | 0.79 |
ENSG00000206797 |
. |
12420 |
0.15 |
chr6_36082377_36082544 | 0.79 |
MAPK13 |
mitogen-activated protein kinase 13 |
15638 |
0.17 |
chr14_71127559_71127720 | 0.79 |
TTC9 |
tetratricopeptide repeat domain 9 |
19135 |
0.2 |
chr19_41626186_41626484 | 0.79 |
CYP2F1 |
cytochrome P450, family 2, subfamily F, polypeptide 1 |
4288 |
0.19 |
chr15_71185021_71185318 | 0.79 |
LRRC49 |
leucine rich repeat containing 49 |
2 |
0.52 |
chr17_47294156_47294371 | 0.79 |
ABI3 |
ABI family, member 3 |
2662 |
0.21 |
chr5_177539858_177540009 | 0.79 |
N4BP3 |
NEDD4 binding protein 3 |
511 |
0.77 |
chr16_24551855_24552006 | 0.79 |
RBBP6 |
retinoblastoma binding protein 6 |
26 |
0.99 |
chr6_91092640_91092855 | 0.79 |
ENSG00000252676 |
. |
63744 |
0.12 |
chr10_8099455_8099947 | 0.79 |
GATA3 |
GATA binding protein 3 |
2932 |
0.41 |
chr4_72053181_72053414 | 0.79 |
SLC4A4 |
solute carrier family 4 (sodium bicarbonate cotransporter), member 4 |
253 |
0.96 |
chr15_75149887_75150088 | 0.78 |
SCAMP2 |
secretory carrier membrane protein 2 |
3060 |
0.15 |
chr13_114817535_114817686 | 0.78 |
RASA3 |
RAS p21 protein activator 3 |
25828 |
0.22 |
chr7_30635395_30635896 | 0.78 |
ENSG00000196295 |
. |
1220 |
0.36 |
chr17_77001932_77002143 | 0.78 |
CANT1 |
calcium activated nucleotidase 1 |
3775 |
0.17 |
chr1_25280715_25280929 | 0.78 |
RP11-84D1.1 |
|
7014 |
0.21 |
chr19_44168465_44168648 | 0.78 |
ENSG00000264133 |
. |
1130 |
0.29 |
chr19_55766821_55767009 | 0.78 |
PPP6R1 |
protein phosphatase 6, regulatory subunit 1 |
222 |
0.84 |
chr1_8212292_8212472 | 0.77 |
ENSG00000200975 |
. |
54275 |
0.13 |
chr13_41215230_41215450 | 0.77 |
FOXO1 |
forkhead box O1 |
25394 |
0.21 |
chr18_66381488_66381790 | 0.77 |
TMX3 |
thioredoxin-related transmembrane protein 3 |
655 |
0.52 |
chr5_138534278_138534453 | 0.77 |
SIL1 |
SIL1 nucleotide exchange factor |
278 |
0.9 |
chr11_128710006_128710157 | 0.77 |
KCNJ1 |
potassium inwardly-rectifying channel, subfamily J, member 1 |
2348 |
0.32 |
chrX_9909563_9909714 | 0.77 |
AC002365.1 |
Homo sapiens uncharacterized LOC100288814 (LOC100288814), mRNA. |
25754 |
0.17 |
chr7_8005309_8005460 | 0.77 |
GLCCI1 |
glucocorticoid induced transcript 1 |
3041 |
0.23 |
chr2_172010707_172010858 | 0.77 |
TLK1 |
tousled-like kinase 1 |
6561 |
0.24 |
chr5_131741727_131741878 | 0.77 |
C5orf56 |
chromosome 5 open reading frame 56 |
4526 |
0.15 |
chr1_100911854_100912179 | 0.77 |
RP5-837M10.4 |
|
39537 |
0.15 |
chr18_60883221_60883629 | 0.77 |
ENSG00000238988 |
. |
21527 |
0.2 |
chr12_9179811_9180299 | 0.77 |
RP11-259O18.4 |
|
30893 |
0.12 |
chr5_169704297_169704473 | 0.77 |
LCP2 |
lymphocyte cytosolic protein 2 (SH2 domain containing leukocyte protein of 76kDa) |
10054 |
0.22 |
chr1_248612578_248612729 | 0.77 |
OR2T2 |
olfactory receptor, family 2, subfamily T, member 2 |
3424 |
0.14 |
chr6_24951319_24951727 | 0.76 |
FAM65B |
family with sequence similarity 65, member B |
15335 |
0.22 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.6 | 2.4 | GO:0030854 | positive regulation of granulocyte differentiation(GO:0030854) |
0.6 | 1.7 | GO:0001672 | regulation of chromatin assembly or disassembly(GO:0001672) |
0.6 | 1.7 | GO:0035405 | histone-threonine phosphorylation(GO:0035405) |
0.5 | 2.2 | GO:0001911 | negative regulation of leukocyte mediated cytotoxicity(GO:0001911) |
0.5 | 2.2 | GO:1901341 | activation of store-operated calcium channel activity(GO:0032237) regulation of store-operated calcium channel activity(GO:1901339) positive regulation of store-operated calcium channel activity(GO:1901341) |
0.5 | 1.6 | GO:0045722 | positive regulation of gluconeogenesis(GO:0045722) |
0.5 | 1.4 | GO:0010459 | negative regulation of heart rate(GO:0010459) |
0.5 | 3.7 | GO:0006491 | N-glycan processing(GO:0006491) |
0.5 | 1.4 | GO:0031946 | regulation of glucocorticoid biosynthetic process(GO:0031946) |
0.4 | 2.2 | GO:0019987 | obsolete negative regulation of anti-apoptosis(GO:0019987) |
0.4 | 1.8 | GO:0045589 | regulation of regulatory T cell differentiation(GO:0045589) |
0.4 | 0.9 | GO:0046642 | negative regulation of alpha-beta T cell proliferation(GO:0046642) |
0.4 | 3.4 | GO:0007172 | signal complex assembly(GO:0007172) |
0.4 | 1.2 | GO:0002666 | T cell tolerance induction(GO:0002517) regulation of T cell tolerance induction(GO:0002664) positive regulation of T cell tolerance induction(GO:0002666) |
0.4 | 1.6 | GO:0050651 | dermatan sulfate proteoglycan biosynthetic process(GO:0050651) |
0.4 | 0.8 | GO:0002713 | negative regulation of B cell mediated immunity(GO:0002713) negative regulation of immunoglobulin mediated immune response(GO:0002890) |
0.4 | 1.1 | GO:0002902 | regulation of B cell apoptotic process(GO:0002902) |
0.4 | 1.1 | GO:0015917 | aminophospholipid transport(GO:0015917) |
0.4 | 0.7 | GO:0002726 | positive regulation of T cell cytokine production(GO:0002726) |
0.4 | 1.8 | GO:0002329 | immature B cell differentiation(GO:0002327) pre-B cell differentiation(GO:0002329) |
0.4 | 1.8 | GO:0031061 | negative regulation of histone methylation(GO:0031061) |
0.3 | 1.0 | GO:0071481 | cellular response to X-ray(GO:0071481) |
0.3 | 0.7 | GO:0045066 | regulatory T cell differentiation(GO:0045066) |
0.3 | 1.0 | GO:0061154 | endothelial tube morphogenesis(GO:0061154) |
0.3 | 0.7 | GO:0002707 | negative regulation of lymphocyte mediated immunity(GO:0002707) |
0.3 | 1.6 | GO:0043984 | histone H4-K16 acetylation(GO:0043984) |
0.3 | 0.6 | GO:2001012 | mesenchymal cell differentiation involved in kidney development(GO:0072161) metanephric mesenchymal cell differentiation(GO:0072162) mesenchymal cell differentiation involved in renal system development(GO:2001012) |
0.3 | 1.0 | GO:0015959 | diadenosine polyphosphate metabolic process(GO:0015959) |
0.3 | 2.5 | GO:0051489 | regulation of filopodium assembly(GO:0051489) |
0.3 | 0.3 | GO:0017085 | response to insecticide(GO:0017085) |
0.3 | 0.9 | GO:0042996 | regulation of Golgi to plasma membrane protein transport(GO:0042996) |
0.3 | 3.7 | GO:0019059 | obsolete initiation of viral infection(GO:0019059) |
0.3 | 0.9 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
0.3 | 0.9 | GO:0046548 | retinal rod cell development(GO:0046548) |
0.3 | 0.9 | GO:0010956 | negative regulation of calcidiol 1-monooxygenase activity(GO:0010956) negative regulation of vitamin D biosynthetic process(GO:0010957) negative regulation of vitamin metabolic process(GO:0046137) |
0.3 | 0.3 | GO:0032675 | interleukin-6 production(GO:0032635) regulation of interleukin-6 production(GO:0032675) |
0.3 | 0.3 | GO:0034765 | regulation of ion transmembrane transport(GO:0034765) |
0.3 | 0.9 | GO:0060766 | negative regulation of androgen receptor signaling pathway(GO:0060766) |
0.3 | 1.1 | GO:0051409 | response to nitrosative stress(GO:0051409) |
0.3 | 1.1 | GO:0043951 | negative regulation of cAMP-mediated signaling(GO:0043951) |
0.3 | 0.8 | GO:0003032 | detection of oxygen(GO:0003032) |
0.3 | 0.8 | GO:0090009 | primitive streak formation(GO:0090009) |
0.3 | 0.8 | GO:0048388 | endosomal lumen acidification(GO:0048388) |
0.3 | 1.3 | GO:0007256 | activation of JNKK activity(GO:0007256) |
0.3 | 0.3 | GO:0008334 | histone mRNA metabolic process(GO:0008334) |
0.3 | 0.5 | GO:0002507 | tolerance induction(GO:0002507) |
0.3 | 0.8 | GO:0002248 | connective tissue replacement involved in inflammatory response wound healing(GO:0002248) connective tissue replacement(GO:0097709) |
0.2 | 1.0 | GO:0010107 | potassium ion import(GO:0010107) |
0.2 | 1.0 | GO:0050685 | positive regulation of mRNA 3'-end processing(GO:0031442) positive regulation of mRNA processing(GO:0050685) positive regulation of mRNA metabolic process(GO:1903313) |
0.2 | 0.7 | GO:0034219 | carbohydrate transmembrane transport(GO:0034219) |
0.2 | 0.7 | GO:0018076 | N-terminal peptidyl-lysine acetylation(GO:0018076) |
0.2 | 0.7 | GO:0006295 | nucleotide-excision repair, DNA incision, 3'-to lesion(GO:0006295) |
0.2 | 0.5 | GO:0007100 | mitotic centrosome separation(GO:0007100) |
0.2 | 1.2 | GO:0008089 | anterograde axonal transport(GO:0008089) |
0.2 | 0.7 | GO:0032506 | cytokinetic process(GO:0032506) |
0.2 | 0.7 | GO:0002313 | mature B cell differentiation involved in immune response(GO:0002313) |
0.2 | 1.4 | GO:0032986 | nucleosome disassembly(GO:0006337) chromatin disassembly(GO:0031498) protein-DNA complex disassembly(GO:0032986) |
0.2 | 0.7 | GO:0072577 | endothelial cell apoptotic process(GO:0072577) epithelial cell apoptotic process(GO:1904019) regulation of epithelial cell apoptotic process(GO:1904035) regulation of endothelial cell apoptotic process(GO:2000351) |
0.2 | 0.2 | GO:0035725 | sodium ion transmembrane transport(GO:0035725) sodium ion export(GO:0071436) |
0.2 | 0.7 | GO:0035054 | embryonic heart tube anterior/posterior pattern specification(GO:0035054) |
0.2 | 0.9 | GO:0071699 | olfactory placode formation(GO:0030910) olfactory placode development(GO:0071698) olfactory placode morphogenesis(GO:0071699) |
0.2 | 0.7 | GO:0050942 | positive regulation of melanocyte differentiation(GO:0045636) positive regulation of pigment cell differentiation(GO:0050942) |
0.2 | 17.1 | GO:0050852 | T cell receptor signaling pathway(GO:0050852) |
0.2 | 0.9 | GO:0046831 | regulation of RNA export from nucleus(GO:0046831) |
0.2 | 0.7 | GO:0002323 | natural killer cell activation involved in immune response(GO:0002323) natural killer cell degranulation(GO:0043320) |
0.2 | 0.2 | GO:0042347 | negative regulation of NF-kappaB import into nucleus(GO:0042347) |
0.2 | 0.7 | GO:0072600 | protein targeting to Golgi(GO:0000042) establishment of protein localization to Golgi(GO:0072600) |
0.2 | 0.7 | GO:0006189 | 'de novo' IMP biosynthetic process(GO:0006189) |
0.2 | 0.7 | GO:0070837 | dehydroascorbic acid transport(GO:0070837) |
0.2 | 0.7 | GO:0033087 | negative regulation of immature T cell proliferation(GO:0033087) negative regulation of immature T cell proliferation in thymus(GO:0033088) |
0.2 | 1.1 | GO:0045714 | regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045714) |
0.2 | 0.7 | GO:0006089 | lactate metabolic process(GO:0006089) |
0.2 | 1.1 | GO:0042989 | sequestering of actin monomers(GO:0042989) |
0.2 | 0.9 | GO:0046606 | negative regulation of centrosome duplication(GO:0010826) negative regulation of centrosome cycle(GO:0046606) |
0.2 | 0.6 | GO:0030186 | melatonin metabolic process(GO:0030186) melatonin biosynthetic process(GO:0030187) |
0.2 | 0.6 | GO:0001821 | histamine secretion(GO:0001821) |
0.2 | 1.7 | GO:0015671 | oxygen transport(GO:0015671) |
0.2 | 0.6 | GO:2000758 | positive regulation of histone acetylation(GO:0035066) positive regulation of protein acetylation(GO:1901985) positive regulation of peptidyl-lysine acetylation(GO:2000758) |
0.2 | 1.4 | GO:0048013 | ephrin receptor signaling pathway(GO:0048013) |
0.2 | 0.4 | GO:0072217 | negative regulation of metanephros development(GO:0072217) |
0.2 | 0.6 | GO:1902931 | negative regulation of alcohol biosynthetic process(GO:1902931) |
0.2 | 0.6 | GO:0031936 | negative regulation of chromatin silencing(GO:0031936) |
0.2 | 1.8 | GO:0000381 | regulation of alternative mRNA splicing, via spliceosome(GO:0000381) |
0.2 | 0.4 | GO:0048199 | vesicle targeting, to, from or within Golgi(GO:0048199) |
0.2 | 0.2 | GO:0021514 | ventral spinal cord interneuron differentiation(GO:0021514) ventral spinal cord interneuron specification(GO:0021521) cell fate specification involved in pattern specification(GO:0060573) ventral spinal cord interneuron fate commitment(GO:0060579) cell fate commitment involved in pattern specification(GO:0060581) |
0.2 | 0.8 | GO:0006689 | ganglioside catabolic process(GO:0006689) |
0.2 | 0.8 | GO:0006422 | aspartyl-tRNA aminoacylation(GO:0006422) |
0.2 | 0.2 | GO:0043374 | CD8-positive, alpha-beta T cell activation(GO:0036037) CD8-positive, alpha-beta T cell differentiation(GO:0043374) |
0.2 | 0.8 | GO:0090322 | regulation of superoxide metabolic process(GO:0090322) |
0.2 | 0.6 | GO:0006772 | thiamine metabolic process(GO:0006772) |
0.2 | 1.5 | GO:2000142 | regulation of transcription initiation from RNA polymerase II promoter(GO:0060260) regulation of DNA-templated transcription, initiation(GO:2000142) |
0.2 | 0.8 | GO:0006999 | nuclear pore organization(GO:0006999) |
0.2 | 0.9 | GO:0000380 | alternative mRNA splicing, via spliceosome(GO:0000380) |
0.2 | 0.6 | GO:0060061 | Spemann organizer formation(GO:0060061) |
0.2 | 0.4 | GO:0034139 | regulation of toll-like receptor 3 signaling pathway(GO:0034139) |
0.2 | 1.5 | GO:0006268 | DNA unwinding involved in DNA replication(GO:0006268) |
0.2 | 1.3 | GO:0042987 | amyloid precursor protein catabolic process(GO:0042987) |
0.2 | 0.2 | GO:0046633 | alpha-beta T cell proliferation(GO:0046633) |
0.2 | 0.2 | GO:0006119 | oxidative phosphorylation(GO:0006119) |
0.2 | 0.2 | GO:0021780 | spinal cord oligodendrocyte cell differentiation(GO:0021529) spinal cord oligodendrocyte cell fate specification(GO:0021530) oligodendrocyte cell fate specification(GO:0021778) glial cell fate specification(GO:0021780) |
0.2 | 0.5 | GO:0019255 | glucose 1-phosphate metabolic process(GO:0019255) |
0.2 | 0.2 | GO:0002448 | mast cell mediated immunity(GO:0002448) |
0.2 | 2.1 | GO:0070536 | protein K63-linked deubiquitination(GO:0070536) |
0.2 | 0.5 | GO:0006384 | transcription initiation from RNA polymerase III promoter(GO:0006384) |
0.2 | 0.4 | GO:0035305 | negative regulation of dephosphorylation(GO:0035305) negative regulation of protein dephosphorylation(GO:0035308) |
0.2 | 0.7 | GO:0032075 | positive regulation of nuclease activity(GO:0032075) |
0.2 | 0.5 | GO:0019985 | translesion synthesis(GO:0019985) |
0.2 | 0.5 | GO:0003323 | type B pancreatic cell development(GO:0003323) |
0.2 | 0.9 | GO:0070389 | chaperone cofactor-dependent protein refolding(GO:0070389) |
0.2 | 0.9 | GO:0000183 | chromatin silencing at rDNA(GO:0000183) |
0.2 | 0.2 | GO:0043653 | mitochondrial fragmentation involved in apoptotic process(GO:0043653) |
0.2 | 3.8 | GO:0000289 | nuclear-transcribed mRNA poly(A) tail shortening(GO:0000289) |
0.2 | 0.7 | GO:0060710 | chorio-allantoic fusion(GO:0060710) |
0.2 | 1.0 | GO:0051294 | establishment of mitotic spindle orientation(GO:0000132) establishment of spindle orientation(GO:0051294) |
0.2 | 0.5 | GO:0001574 | ganglioside biosynthetic process(GO:0001574) |
0.2 | 0.7 | GO:0006301 | postreplication repair(GO:0006301) |
0.2 | 0.5 | GO:1902101 | positive regulation of mitotic metaphase/anaphase transition(GO:0045842) positive regulation of mitotic sister chromatid separation(GO:1901970) positive regulation of metaphase/anaphase transition of cell cycle(GO:1902101) |
0.2 | 0.5 | GO:0042518 | negative regulation of tyrosine phosphorylation of Stat3 protein(GO:0042518) |
0.2 | 0.7 | GO:0003056 | regulation of vascular smooth muscle contraction(GO:0003056) |
0.2 | 0.2 | GO:0007000 | nucleolus organization(GO:0007000) |
0.2 | 0.7 | GO:0002691 | regulation of cellular extravasation(GO:0002691) |
0.2 | 0.6 | GO:0006269 | DNA replication, synthesis of RNA primer(GO:0006269) |
0.2 | 0.5 | GO:0006642 | triglyceride mobilization(GO:0006642) |
0.2 | 0.6 | GO:0006924 | activation-induced cell death of T cells(GO:0006924) |
0.2 | 0.6 | GO:0006564 | L-serine biosynthetic process(GO:0006564) |
0.2 | 0.3 | GO:0060750 | epithelial cell proliferation involved in mammary gland duct elongation(GO:0060750) branch elongation involved in mammary gland duct branching(GO:0060751) |
0.2 | 0.3 | GO:0040001 | establishment of mitotic spindle localization(GO:0040001) |
0.2 | 0.2 | GO:0055075 | potassium ion homeostasis(GO:0055075) |
0.2 | 0.5 | GO:0034720 | histone H3-K4 demethylation(GO:0034720) |
0.2 | 0.5 | GO:0072133 | kidney mesenchyme morphogenesis(GO:0072131) metanephric mesenchyme morphogenesis(GO:0072133) |
0.2 | 0.6 | GO:0046605 | regulation of centrosome cycle(GO:0046605) |
0.2 | 0.5 | GO:0039656 | modulation by virus of host gene expression(GO:0039656) |
0.2 | 0.5 | GO:0006011 | UDP-glucose metabolic process(GO:0006011) |
0.2 | 0.2 | GO:0070561 | vitamin D receptor signaling pathway(GO:0070561) |
0.2 | 0.5 | GO:0010944 | negative regulation of transcription by competitive promoter binding(GO:0010944) |
0.2 | 0.2 | GO:0090400 | stress-induced premature senescence(GO:0090400) |
0.2 | 0.2 | GO:0008608 | attachment of spindle microtubules to kinetochore(GO:0008608) |
0.2 | 0.3 | GO:0071379 | cellular response to prostaglandin stimulus(GO:0071379) |
0.2 | 0.5 | GO:0010508 | positive regulation of autophagy(GO:0010508) |
0.2 | 2.7 | GO:0060330 | regulation of response to interferon-gamma(GO:0060330) regulation of interferon-gamma-mediated signaling pathway(GO:0060334) |
0.1 | 0.3 | GO:0006883 | cellular sodium ion homeostasis(GO:0006883) |
0.1 | 0.7 | GO:0072583 | synaptic vesicle recycling(GO:0036465) synaptic vesicle endocytosis(GO:0048488) clathrin-mediated endocytosis(GO:0072583) |
0.1 | 1.5 | GO:0000085 | mitotic G2 phase(GO:0000085) G2 phase(GO:0051319) |
0.1 | 0.6 | GO:1900087 | traversing start control point of mitotic cell cycle(GO:0007089) positive regulation of G1/S transition of mitotic cell cycle(GO:1900087) positive regulation of cell cycle G1/S phase transition(GO:1902808) |
0.1 | 0.4 | GO:0060999 | positive regulation of dendritic spine development(GO:0060999) |
0.1 | 0.7 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
0.1 | 0.1 | GO:0032653 | regulation of interleukin-10 production(GO:0032653) |
0.1 | 1.2 | GO:0018216 | peptidyl-arginine methylation(GO:0018216) |
0.1 | 0.7 | GO:0071166 | ribonucleoprotein complex localization(GO:0071166) |
0.1 | 0.3 | GO:0016553 | base conversion or substitution editing(GO:0016553) |
0.1 | 0.4 | GO:0014889 | muscle atrophy(GO:0014889) |
0.1 | 0.9 | GO:0032119 | sequestering of zinc ion(GO:0032119) |
0.1 | 0.4 | GO:0015801 | aromatic amino acid transport(GO:0015801) |
0.1 | 1.0 | GO:0060123 | regulation of growth hormone secretion(GO:0060123) |
0.1 | 0.9 | GO:0001562 | response to protozoan(GO:0001562) defense response to protozoan(GO:0042832) |
0.1 | 0.6 | GO:0042359 | vitamin D metabolic process(GO:0042359) |
0.1 | 0.3 | GO:0002523 | leukocyte migration involved in inflammatory response(GO:0002523) |
0.1 | 0.1 | GO:0002328 | pro-B cell differentiation(GO:0002328) |
0.1 | 0.4 | GO:0032097 | positive regulation of response to food(GO:0032097) positive regulation of appetite(GO:0032100) |
0.1 | 0.1 | GO:0021904 | dorsal/ventral neural tube patterning(GO:0021904) |
0.1 | 0.4 | GO:0006434 | seryl-tRNA aminoacylation(GO:0006434) |
0.1 | 0.3 | GO:0042492 | gamma-delta T cell differentiation(GO:0042492) |
0.1 | 1.1 | GO:0006983 | ER overload response(GO:0006983) |
0.1 | 0.4 | GO:0007181 | transforming growth factor beta receptor complex assembly(GO:0007181) |
0.1 | 0.3 | GO:0034392 | negative regulation of smooth muscle cell apoptotic process(GO:0034392) |
0.1 | 0.7 | GO:0050667 | homocysteine metabolic process(GO:0050667) |
0.1 | 0.3 | GO:0001912 | positive regulation of leukocyte mediated cytotoxicity(GO:0001912) |
0.1 | 0.4 | GO:0010815 | bradykinin catabolic process(GO:0010815) |
0.1 | 0.4 | GO:0045906 | negative regulation of vasoconstriction(GO:0045906) |
0.1 | 0.4 | GO:0001831 | trophectodermal cellular morphogenesis(GO:0001831) |
0.1 | 5.1 | GO:0031124 | mRNA 3'-end processing(GO:0031124) |
0.1 | 0.3 | GO:0046121 | deoxyribonucleoside catabolic process(GO:0046121) |
0.1 | 1.2 | GO:0010390 | histone monoubiquitination(GO:0010390) |
0.1 | 0.3 | GO:0046719 | intracellular transport of viral protein in host cell(GO:0019060) symbiont intracellular protein transport in host(GO:0030581) regulation by virus of viral protein levels in host cell(GO:0046719) intracellular protein transport in other organism involved in symbiotic interaction(GO:0051708) |
0.1 | 0.7 | GO:0002063 | chondrocyte development(GO:0002063) |
0.1 | 1.1 | GO:0043124 | negative regulation of I-kappaB kinase/NF-kappaB signaling(GO:0043124) |
0.1 | 0.4 | GO:0006167 | AMP biosynthetic process(GO:0006167) |
0.1 | 0.1 | GO:0009189 | deoxyribonucleoside diphosphate biosynthetic process(GO:0009189) |
0.1 | 0.1 | GO:0007096 | regulation of exit from mitosis(GO:0007096) |
0.1 | 0.4 | GO:0043568 | positive regulation of insulin-like growth factor receptor signaling pathway(GO:0043568) |
0.1 | 0.4 | GO:0000470 | maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000463) maturation of LSU-rRNA(GO:0000470) |
0.1 | 0.3 | GO:0032776 | DNA methylation on cytosine(GO:0032776) C-5 methylation of cytosine(GO:0090116) |
0.1 | 0.1 | GO:0097576 | vacuole fusion(GO:0097576) |
0.1 | 0.3 | GO:0042110 | T cell activation(GO:0042110) leukocyte aggregation(GO:0070486) T cell aggregation(GO:0070489) lymphocyte aggregation(GO:0071593) |
0.1 | 0.3 | GO:0017014 | protein nitrosylation(GO:0017014) peptidyl-cysteine S-nitrosylation(GO:0018119) |
0.1 | 0.3 | GO:0045074 | interleukin-10 biosynthetic process(GO:0042091) regulation of interleukin-10 biosynthetic process(GO:0045074) |
0.1 | 0.5 | GO:0006474 | N-terminal protein amino acid acetylation(GO:0006474) |
0.1 | 0.4 | GO:0007195 | adenylate cyclase-inhibiting dopamine receptor signaling pathway(GO:0007195) |
0.1 | 0.7 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
0.1 | 0.5 | GO:0035092 | sperm chromatin condensation(GO:0035092) |
0.1 | 0.4 | GO:0060084 | synaptic transmission involved in micturition(GO:0060084) |
0.1 | 0.1 | GO:0000733 | DNA strand renaturation(GO:0000733) |
0.1 | 0.4 | GO:0061030 | epithelial cell differentiation involved in mammary gland alveolus development(GO:0061030) |
0.1 | 1.2 | GO:0016574 | histone ubiquitination(GO:0016574) |
0.1 | 0.1 | GO:0045835 | negative regulation of meiotic nuclear division(GO:0045835) |
0.1 | 0.6 | GO:0006111 | regulation of gluconeogenesis(GO:0006111) |
0.1 | 0.4 | GO:0047484 | regulation of response to osmotic stress(GO:0047484) |
0.1 | 0.4 | GO:0090047 | obsolete positive regulation of transcription regulator activity(GO:0090047) |
0.1 | 0.3 | GO:0048861 | leukemia inhibitory factor signaling pathway(GO:0048861) |
0.1 | 1.2 | GO:0046519 | sphingoid metabolic process(GO:0046519) |
0.1 | 0.8 | GO:0006002 | fructose 6-phosphate metabolic process(GO:0006002) |
0.1 | 0.9 | GO:0016255 | attachment of GPI anchor to protein(GO:0016255) |
0.1 | 0.5 | GO:0017182 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) |
0.1 | 0.1 | GO:0021889 | olfactory bulb interneuron differentiation(GO:0021889) olfactory bulb interneuron development(GO:0021891) |
0.1 | 0.3 | GO:0006975 | DNA damage induced protein phosphorylation(GO:0006975) |
0.1 | 0.8 | GO:0031115 | negative regulation of microtubule polymerization(GO:0031115) |
0.1 | 0.3 | GO:0034122 | negative regulation of toll-like receptor signaling pathway(GO:0034122) |
0.1 | 0.1 | GO:0010614 | negative regulation of cardiac muscle hypertrophy(GO:0010614) negative regulation of muscle hypertrophy(GO:0014741) |
0.1 | 1.5 | GO:0071044 | histone mRNA catabolic process(GO:0071044) |
0.1 | 0.1 | GO:0002834 | regulation of response to tumor cell(GO:0002834) positive regulation of response to tumor cell(GO:0002836) regulation of immune response to tumor cell(GO:0002837) positive regulation of immune response to tumor cell(GO:0002839) |
0.1 | 0.4 | GO:0061687 | detoxification of inorganic compound(GO:0061687) stress response to metal ion(GO:0097501) |
0.1 | 0.1 | GO:0034314 | Arp2/3 complex-mediated actin nucleation(GO:0034314) |
0.1 | 0.6 | GO:0048617 | embryonic foregut morphogenesis(GO:0048617) |
0.1 | 0.2 | GO:0009296 | obsolete flagellum assembly(GO:0009296) |
0.1 | 0.5 | GO:0045084 | positive regulation of interleukin-12 biosynthetic process(GO:0045084) |
0.1 | 0.4 | GO:0060770 | negative regulation of epithelial cell proliferation involved in prostate gland development(GO:0060770) |
0.1 | 0.7 | GO:0051797 | regulation of hair cycle(GO:0042634) regulation of hair follicle development(GO:0051797) |
0.1 | 0.4 | GO:0035751 | lysosomal lumen acidification(GO:0007042) regulation of lysosomal lumen pH(GO:0035751) |
0.1 | 0.2 | GO:0036230 | granulocyte activation(GO:0036230) neutrophil activation(GO:0042119) |
0.1 | 0.5 | GO:0000012 | single strand break repair(GO:0000012) |
0.1 | 0.2 | GO:0002072 | optic cup morphogenesis involved in camera-type eye development(GO:0002072) |
0.1 | 1.6 | GO:0042776 | mitochondrial ATP synthesis coupled proton transport(GO:0042776) |
0.1 | 0.5 | GO:0046579 | positive regulation of Ras protein signal transduction(GO:0046579) |
0.1 | 0.4 | GO:0034453 | microtubule anchoring(GO:0034453) |
0.1 | 0.6 | GO:0042023 | regulation of DNA endoreduplication(GO:0032875) negative regulation of DNA endoreduplication(GO:0032876) DNA endoreduplication(GO:0042023) |
0.1 | 0.5 | GO:0010626 | regulation of Schwann cell proliferation(GO:0010624) negative regulation of Schwann cell proliferation(GO:0010626) Schwann cell proliferation(GO:0014010) |
0.1 | 0.6 | GO:0006287 | base-excision repair, gap-filling(GO:0006287) |
0.1 | 0.4 | GO:0045292 | mRNA cis splicing, via spliceosome(GO:0045292) |
0.1 | 0.5 | GO:0000389 | mRNA 3'-splice site recognition(GO:0000389) |
0.1 | 0.4 | GO:0035455 | response to interferon-alpha(GO:0035455) |
0.1 | 0.2 | GO:0060596 | mammary placode formation(GO:0060596) |
0.1 | 2.2 | GO:0000245 | spliceosomal complex assembly(GO:0000245) |
0.1 | 0.5 | GO:0033261 | obsolete regulation of S phase(GO:0033261) |
0.1 | 0.2 | GO:0002418 | immune response to tumor cell(GO:0002418) |
0.1 | 0.4 | GO:1901522 | positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus(GO:1901522) |
0.1 | 0.7 | GO:0060009 | Sertoli cell development(GO:0060009) |
0.1 | 0.4 | GO:0002430 | complement receptor mediated signaling pathway(GO:0002430) |
0.1 | 0.4 | GO:0019471 | peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) 4-hydroxyproline metabolic process(GO:0019471) peptidyl-proline hydroxylation(GO:0019511) |
0.1 | 0.1 | GO:0043619 | regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0043619) |
0.1 | 0.5 | GO:0022614 | membrane to membrane docking(GO:0022614) |
0.1 | 0.1 | GO:0010216 | maintenance of DNA methylation(GO:0010216) |
0.1 | 0.1 | GO:0032461 | positive regulation of protein oligomerization(GO:0032461) |
0.1 | 0.2 | GO:0072224 | metanephric glomerulus development(GO:0072224) metanephric glomerulus vasculature development(GO:0072239) |
0.1 | 0.2 | GO:0046185 | aldehyde catabolic process(GO:0046185) |
0.1 | 0.2 | GO:0009048 | dosage compensation by inactivation of X chromosome(GO:0009048) |
0.1 | 0.6 | GO:0046835 | carbohydrate phosphorylation(GO:0046835) |
0.1 | 0.5 | GO:0044314 | protein K27-linked ubiquitination(GO:0044314) |
0.1 | 0.5 | GO:0060438 | trachea development(GO:0060438) |
0.1 | 0.8 | GO:0007253 | cytoplasmic sequestering of NF-kappaB(GO:0007253) |
0.1 | 0.8 | GO:0008653 | lipopolysaccharide metabolic process(GO:0008653) |
0.1 | 0.5 | GO:0051657 | maintenance of organelle location(GO:0051657) |
0.1 | 0.1 | GO:0006405 | RNA export from nucleus(GO:0006405) |
0.1 | 2.7 | GO:0031294 | lymphocyte costimulation(GO:0031294) T cell costimulation(GO:0031295) |
0.1 | 0.3 | GO:0000089 | mitotic metaphase(GO:0000089) |
0.1 | 1.2 | GO:0006359 | regulation of transcription from RNA polymerase III promoter(GO:0006359) |
0.1 | 0.6 | GO:0002483 | antigen processing and presentation of endogenous peptide antigen(GO:0002483) antigen processing and presentation of endogenous peptide antigen via MHC class I(GO:0019885) |
0.1 | 0.2 | GO:0042109 | lymphotoxin A production(GO:0032641) lymphotoxin A biosynthetic process(GO:0042109) |
0.1 | 1.8 | GO:0034199 | activation of protein kinase A activity(GO:0034199) |
0.1 | 0.3 | GO:0045746 | negative regulation of Notch signaling pathway(GO:0045746) |
0.1 | 0.2 | GO:0010979 | regulation of vitamin D 24-hydroxylase activity(GO:0010979) positive regulation of vitamin D 24-hydroxylase activity(GO:0010980) |
0.1 | 0.1 | GO:0001973 | adenosine receptor signaling pathway(GO:0001973) G-protein coupled purinergic receptor signaling pathway(GO:0035588) |
0.1 | 0.3 | GO:0035609 | C-terminal protein deglutamylation(GO:0035609) protein side chain deglutamylation(GO:0035610) |
0.1 | 1.0 | GO:0051568 | histone H3-K4 methylation(GO:0051568) |
0.1 | 0.1 | GO:0007494 | midgut development(GO:0007494) |
0.1 | 0.4 | GO:0032747 | positive regulation of interleukin-23 production(GO:0032747) |
0.1 | 4.0 | GO:0006120 | mitochondrial electron transport, NADH to ubiquinone(GO:0006120) |
0.1 | 7.2 | GO:0000216 | obsolete M/G1 transition of mitotic cell cycle(GO:0000216) |
0.1 | 0.4 | GO:0070670 | response to interleukin-4(GO:0070670) |
0.1 | 0.3 | GO:0006391 | transcription initiation from mitochondrial promoter(GO:0006391) |
0.1 | 0.3 | GO:0097094 | cranial suture morphogenesis(GO:0060363) craniofacial suture morphogenesis(GO:0097094) |
0.1 | 0.4 | GO:2000258 | negative regulation of humoral immune response(GO:0002921) negative regulation of complement activation(GO:0045916) negative regulation of protein activation cascade(GO:2000258) |
0.1 | 0.1 | GO:0001766 | membrane raft polarization(GO:0001766) membrane raft organization(GO:0031579) membrane raft distribution(GO:0031580) membrane raft localization(GO:0051665) |
0.1 | 0.3 | GO:0030505 | inorganic diphosphate transport(GO:0030505) |
0.1 | 0.3 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
0.1 | 0.1 | GO:0050765 | negative regulation of phagocytosis(GO:0050765) |
0.1 | 0.4 | GO:0048864 | stem cell development(GO:0048864) |
0.1 | 0.2 | GO:0070935 | 3'-UTR-mediated mRNA stabilization(GO:0070935) |
0.1 | 0.3 | GO:0003099 | positive regulation of the force of heart contraction by chemical signal(GO:0003099) |
0.1 | 1.0 | GO:0031648 | protein destabilization(GO:0031648) |
0.1 | 0.2 | GO:0022027 | interkinetic nuclear migration(GO:0022027) |
0.1 | 0.1 | GO:0010613 | positive regulation of cardiac muscle hypertrophy(GO:0010613) positive regulation of muscle hypertrophy(GO:0014742) |
0.1 | 0.9 | GO:0043508 | negative regulation of JUN kinase activity(GO:0043508) |
0.1 | 0.4 | GO:0007191 | adenylate cyclase-activating dopamine receptor signaling pathway(GO:0007191) |
0.1 | 0.2 | GO:0001705 | ectoderm formation(GO:0001705) |
0.1 | 0.2 | GO:0032713 | negative regulation of interleukin-4 production(GO:0032713) |
0.1 | 0.2 | GO:0009120 | deoxyribonucleoside metabolic process(GO:0009120) |
0.1 | 0.6 | GO:0016584 | nucleosome positioning(GO:0016584) |
0.1 | 0.7 | GO:0043550 | regulation of lipid kinase activity(GO:0043550) |
0.1 | 0.2 | GO:0034421 | post-translational protein acetylation(GO:0034421) |
0.1 | 0.1 | GO:0010533 | regulation of activation of Janus kinase activity(GO:0010533) positive regulation of activation of Janus kinase activity(GO:0010536) |
0.1 | 0.3 | GO:0007095 | mitotic G2 DNA damage checkpoint(GO:0007095) |
0.1 | 0.6 | GO:0002360 | T cell lineage commitment(GO:0002360) |
0.1 | 0.1 | GO:0010831 | positive regulation of myotube differentiation(GO:0010831) |
0.1 | 0.2 | GO:0060242 | contact inhibition(GO:0060242) |
0.1 | 0.6 | GO:0046784 | viral mRNA export from host cell nucleus(GO:0046784) |
0.1 | 0.2 | GO:0052251 | induction by organism of defense response of other organism involved in symbiotic interaction(GO:0052251) |
0.1 | 0.3 | GO:0032212 | positive regulation of telomere maintenance via telomerase(GO:0032212) positive regulation of telomere maintenance via telomere lengthening(GO:1904358) |
0.1 | 0.1 | GO:0045824 | negative regulation of innate immune response(GO:0045824) |
0.1 | 0.8 | GO:0060644 | mammary gland epithelial cell differentiation(GO:0060644) |
0.1 | 0.4 | GO:0042219 | cellular modified amino acid catabolic process(GO:0042219) |
0.1 | 0.6 | GO:0015780 | nucleotide-sugar transport(GO:0015780) |
0.1 | 0.1 | GO:0006265 | DNA topological change(GO:0006265) |
0.1 | 0.3 | GO:0045056 | transcytosis(GO:0045056) |
0.1 | 0.3 | GO:0051531 | NFAT protein import into nucleus(GO:0051531) regulation of NFAT protein import into nucleus(GO:0051532) |
0.1 | 0.3 | GO:0071569 | protein ufmylation(GO:0071569) |
0.1 | 0.5 | GO:0009298 | GDP-mannose biosynthetic process(GO:0009298) |
0.1 | 1.2 | GO:0007076 | mitotic chromosome condensation(GO:0007076) |
0.1 | 0.4 | GO:0008333 | endosome to lysosome transport(GO:0008333) |
0.1 | 0.1 | GO:0048566 | embryonic digestive tract development(GO:0048566) |
0.1 | 1.5 | GO:0042267 | natural killer cell mediated immunity(GO:0002228) natural killer cell mediated cytotoxicity(GO:0042267) |
0.1 | 0.2 | GO:0016572 | histone phosphorylation(GO:0016572) |
0.1 | 1.0 | GO:0000184 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:0000184) |
0.1 | 0.1 | GO:0090192 | regulation of glomerulus development(GO:0090192) |
0.1 | 1.0 | GO:0045947 | negative regulation of translational initiation(GO:0045947) |
0.1 | 0.2 | GO:0006154 | adenosine catabolic process(GO:0006154) |
0.1 | 0.6 | GO:0006538 | glutamate catabolic process(GO:0006538) |
0.1 | 0.1 | GO:0042088 | T-helper 1 type immune response(GO:0042088) |
0.1 | 1.6 | GO:0043484 | regulation of RNA splicing(GO:0043484) |
0.1 | 0.4 | GO:0051790 | short-chain fatty acid biosynthetic process(GO:0051790) |
0.1 | 0.5 | GO:0018202 | peptidyl-histidine phosphorylation(GO:0018106) peptidyl-histidine modification(GO:0018202) |
0.1 | 0.9 | GO:0010921 | regulation of phosphatase activity(GO:0010921) |
0.1 | 0.3 | GO:0044380 | protein localization to cytoskeleton(GO:0044380) protein localization to microtubule cytoskeleton(GO:0072698) |
0.1 | 0.2 | GO:2000114 | regulation of establishment of cell polarity(GO:2000114) |
0.1 | 0.1 | GO:0003402 | planar cell polarity pathway involved in axis elongation(GO:0003402) |
0.1 | 0.6 | GO:0042891 | tetracycline transport(GO:0015904) antibiotic transport(GO:0042891) toxin transport(GO:1901998) |
0.1 | 2.7 | GO:0042147 | retrograde transport, endosome to Golgi(GO:0042147) |
0.1 | 0.4 | GO:0051387 | negative regulation of neurotrophin TRK receptor signaling pathway(GO:0051387) |
0.1 | 0.1 | GO:0016556 | mRNA modification(GO:0016556) |
0.1 | 0.2 | GO:0043631 | RNA polyadenylation(GO:0043631) |
0.1 | 0.4 | GO:0001773 | myeloid dendritic cell activation(GO:0001773) |
0.1 | 0.8 | GO:0061515 | erythrocyte development(GO:0048821) myeloid cell development(GO:0061515) |
0.1 | 0.2 | GO:0051322 | anaphase(GO:0051322) |
0.1 | 6.0 | GO:0051028 | mRNA transport(GO:0051028) |
0.1 | 0.1 | GO:0045793 | positive regulation of cell size(GO:0045793) |
0.1 | 0.6 | GO:0006521 | regulation of cellular amino acid metabolic process(GO:0006521) |
0.1 | 0.6 | GO:0000718 | nucleotide-excision repair, DNA damage removal(GO:0000718) DNA excision(GO:0044349) |
0.1 | 2.6 | GO:0006888 | ER to Golgi vesicle-mediated transport(GO:0006888) |
0.1 | 0.1 | GO:0046007 | negative regulation of activated T cell proliferation(GO:0046007) |
0.1 | 0.4 | GO:0042130 | negative regulation of T cell proliferation(GO:0042130) |
0.1 | 0.9 | GO:0035964 | COPI-coated vesicle budding(GO:0035964) Golgi vesicle budding(GO:0048194) Golgi transport vesicle coating(GO:0048200) COPI coating of Golgi vesicle(GO:0048205) |
0.1 | 0.9 | GO:0007158 | neuron cell-cell adhesion(GO:0007158) |
0.1 | 0.2 | GO:0060972 | left/right pattern formation(GO:0060972) |
0.1 | 0.7 | GO:0006270 | DNA replication initiation(GO:0006270) |
0.1 | 0.5 | GO:0006561 | proline biosynthetic process(GO:0006561) |
0.1 | 0.3 | GO:0051895 | negative regulation of focal adhesion assembly(GO:0051895) negative regulation of cell junction assembly(GO:1901889) negative regulation of adherens junction organization(GO:1903392) |
0.1 | 0.1 | GO:0060433 | bronchus development(GO:0060433) |
0.1 | 0.5 | GO:0042640 | anagen(GO:0042640) |
0.1 | 0.4 | GO:0006104 | succinyl-CoA metabolic process(GO:0006104) |
0.1 | 0.4 | GO:0006342 | chromatin silencing(GO:0006342) |
0.1 | 0.3 | GO:0045002 | DNA double-strand break processing involved in repair via single-strand annealing(GO:0010792) double-strand break repair via single-strand annealing(GO:0045002) |
0.1 | 0.3 | GO:0060743 | epithelial cell maturation involved in prostate gland development(GO:0060743) |
0.1 | 0.2 | GO:0043162 | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043162) |
0.1 | 0.6 | GO:0048873 | homeostasis of number of cells within a tissue(GO:0048873) |
0.1 | 0.6 | GO:0032464 | positive regulation of protein homooligomerization(GO:0032464) |
0.1 | 0.5 | GO:0007157 | heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0007157) |
0.1 | 0.3 | GO:0043276 | anoikis(GO:0043276) |
0.1 | 0.9 | GO:0021516 | dorsal spinal cord development(GO:0021516) |
0.1 | 0.1 | GO:0006106 | fumarate metabolic process(GO:0006106) |
0.1 | 0.1 | GO:0048087 | positive regulation of developmental pigmentation(GO:0048087) |
0.1 | 0.2 | GO:0042149 | cellular response to glucose starvation(GO:0042149) |
0.1 | 0.4 | GO:0007097 | nuclear migration(GO:0007097) |
0.1 | 0.3 | GO:0006379 | mRNA cleavage(GO:0006379) |
0.1 | 1.3 | GO:0032012 | regulation of ARF protein signal transduction(GO:0032012) |
0.1 | 3.6 | GO:0070646 | protein modification by small protein removal(GO:0070646) |
0.1 | 0.7 | GO:0015074 | DNA integration(GO:0015074) |
0.1 | 0.4 | GO:0032486 | Rap protein signal transduction(GO:0032486) |
0.1 | 0.5 | GO:0008611 | ether lipid biosynthetic process(GO:0008611) glycerol ether biosynthetic process(GO:0046504) ether biosynthetic process(GO:1901503) |
0.1 | 1.4 | GO:0016601 | Rac protein signal transduction(GO:0016601) |
0.1 | 0.1 | GO:0071636 | positive regulation of transforming growth factor beta production(GO:0071636) |
0.1 | 0.4 | GO:0042448 | progesterone metabolic process(GO:0042448) |
0.1 | 0.3 | GO:0060292 | long term synaptic depression(GO:0060292) |
0.1 | 0.8 | GO:0032456 | endocytic recycling(GO:0032456) |
0.1 | 0.1 | GO:0006991 | response to sterol depletion(GO:0006991) SREBP signaling pathway(GO:0032933) cellular response to sterol depletion(GO:0071501) |
0.1 | 0.3 | GO:0043923 | positive regulation by host of viral transcription(GO:0043923) |
0.1 | 0.3 | GO:0035025 | positive regulation of Rho protein signal transduction(GO:0035025) |
0.1 | 0.3 | GO:0006177 | GMP biosynthetic process(GO:0006177) |
0.1 | 0.7 | GO:0007219 | Notch signaling pathway(GO:0007219) |
0.1 | 0.3 | GO:0034629 | cellular protein complex localization(GO:0034629) |
0.1 | 0.4 | GO:0070584 | mitochondrion morphogenesis(GO:0070584) |
0.1 | 0.3 | GO:0043407 | negative regulation of MAP kinase activity(GO:0043407) |
0.1 | 0.1 | GO:0060586 | multicellular organismal iron ion homeostasis(GO:0060586) |
0.1 | 0.5 | GO:0043403 | skeletal muscle tissue regeneration(GO:0043403) |
0.1 | 0.3 | GO:0032730 | regulation of interleukin-1 alpha production(GO:0032650) positive regulation of interleukin-1 alpha production(GO:0032730) |
0.1 | 0.1 | GO:0000492 | small nucleolar ribonucleoprotein complex assembly(GO:0000491) box C/D snoRNP assembly(GO:0000492) |
0.1 | 0.1 | GO:0032922 | circadian regulation of gene expression(GO:0032922) |
0.1 | 0.1 | GO:0034085 | establishment of sister chromatid cohesion(GO:0034085) cohesin loading(GO:0071921) regulation of cohesin loading(GO:0071922) |
0.1 | 0.8 | GO:0071158 | positive regulation of cell cycle arrest(GO:0071158) |
0.1 | 0.2 | GO:0007212 | dopamine receptor signaling pathway(GO:0007212) |
0.1 | 1.5 | GO:0015949 | nucleobase-containing small molecule interconversion(GO:0015949) |
0.1 | 0.1 | GO:0032729 | positive regulation of interferon-gamma production(GO:0032729) |
0.1 | 0.2 | GO:0045814 | negative regulation of gene expression, epigenetic(GO:0045814) |
0.1 | 0.2 | GO:0051299 | centrosome separation(GO:0051299) |
0.1 | 0.1 | GO:0006997 | nucleus organization(GO:0006997) |
0.1 | 0.3 | GO:0007021 | tubulin complex assembly(GO:0007021) |
0.1 | 0.5 | GO:0006516 | glycoprotein catabolic process(GO:0006516) |
0.1 | 0.4 | GO:0036473 | intrinsic apoptotic signaling pathway in response to oxidative stress(GO:0008631) cell death in response to oxidative stress(GO:0036473) |
0.1 | 0.1 | GO:0032462 | regulation of protein homooligomerization(GO:0032462) |
0.1 | 0.5 | GO:0045070 | positive regulation of viral genome replication(GO:0045070) |
0.1 | 0.1 | GO:0045060 | negative T cell selection(GO:0043383) negative thymic T cell selection(GO:0045060) thymic T cell selection(GO:0045061) |
0.1 | 0.3 | GO:0006435 | threonyl-tRNA aminoacylation(GO:0006435) |
0.1 | 0.3 | GO:0007090 | obsolete regulation of S phase of mitotic cell cycle(GO:0007090) |
0.1 | 0.2 | GO:0019724 | B cell mediated immunity(GO:0019724) |
0.1 | 0.2 | GO:0048263 | determination of dorsal identity(GO:0048263) |
0.1 | 0.2 | GO:0008298 | intracellular mRNA localization(GO:0008298) |
0.1 | 0.2 | GO:0098534 | centriole replication(GO:0007099) centriole assembly(GO:0098534) |
0.1 | 2.3 | GO:0006383 | transcription from RNA polymerase III promoter(GO:0006383) |
0.1 | 0.3 | GO:0006998 | nuclear envelope organization(GO:0006998) |
0.1 | 1.8 | GO:0006361 | transcription initiation from RNA polymerase I promoter(GO:0006361) |
0.1 | 0.1 | GO:0048715 | negative regulation of oligodendrocyte differentiation(GO:0048715) |
0.1 | 0.5 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
0.1 | 0.4 | GO:0006878 | cellular copper ion homeostasis(GO:0006878) |
0.1 | 0.9 | GO:0007062 | sister chromatid cohesion(GO:0007062) |
0.1 | 0.2 | GO:0051775 | response to redox state(GO:0051775) |
0.1 | 0.2 | GO:0044240 | multicellular organism lipid catabolic process(GO:0044240) |
0.1 | 0.2 | GO:0033683 | nucleotide-excision repair, DNA incision(GO:0033683) |
0.1 | 0.7 | GO:0007032 | endosome organization(GO:0007032) |
0.1 | 0.3 | GO:0001782 | B cell homeostasis(GO:0001782) |
0.1 | 0.2 | GO:0010389 | regulation of G2/M transition of mitotic cell cycle(GO:0010389) regulation of cell cycle G2/M phase transition(GO:1902749) |
0.1 | 0.2 | GO:0009405 | pathogenesis(GO:0009405) |
0.1 | 0.9 | GO:0006891 | intra-Golgi vesicle-mediated transport(GO:0006891) |
0.1 | 0.2 | GO:0046101 | hypoxanthine biosynthetic process(GO:0046101) |
0.1 | 0.1 | GO:0022417 | protein maturation by protein folding(GO:0022417) |
0.1 | 0.6 | GO:0050853 | B cell receptor signaling pathway(GO:0050853) |
0.1 | 0.2 | GO:0007638 | mechanosensory behavior(GO:0007638) |
0.1 | 0.1 | GO:0070265 | necrotic cell death(GO:0070265) |
0.1 | 0.3 | GO:0045885 | obsolete positive regulation of survival gene product expression(GO:0045885) |
0.1 | 0.3 | GO:0070059 | intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress(GO:0070059) |
0.1 | 2.0 | GO:1903051 | negative regulation of proteolysis involved in cellular protein catabolic process(GO:1903051) |
0.1 | 0.1 | GO:0045618 | positive regulation of keratinocyte differentiation(GO:0045618) |
0.1 | 0.3 | GO:0070071 | proton-transporting two-sector ATPase complex assembly(GO:0070071) |
0.1 | 0.6 | GO:0031146 | SCF-dependent proteasomal ubiquitin-dependent protein catabolic process(GO:0031146) |
0.1 | 1.0 | GO:0071230 | cellular response to amino acid stimulus(GO:0071230) |
0.1 | 0.1 | GO:0055078 | sodium ion homeostasis(GO:0055078) |
0.1 | 0.2 | GO:0032988 | ribonucleoprotein complex disassembly(GO:0032988) |
0.1 | 1.3 | GO:0008633 | obsolete activation of pro-apoptotic gene products(GO:0008633) |
0.1 | 0.2 | GO:0010828 | positive regulation of glucose transport(GO:0010828) |
0.1 | 0.9 | GO:0045730 | respiratory burst(GO:0045730) |
0.1 | 0.2 | GO:0010642 | negative regulation of platelet-derived growth factor receptor signaling pathway(GO:0010642) |
0.1 | 1.6 | GO:0070936 | protein K48-linked ubiquitination(GO:0070936) |
0.1 | 0.4 | GO:0000083 | regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0000083) |
0.1 | 0.4 | GO:0034587 | piRNA metabolic process(GO:0034587) |
0.1 | 0.2 | GO:0010332 | response to gamma radiation(GO:0010332) |
0.1 | 0.2 | GO:0043628 | ncRNA 3'-end processing(GO:0043628) |
0.1 | 0.5 | GO:0032098 | regulation of appetite(GO:0032098) |
0.1 | 0.1 | GO:0071800 | podosome assembly(GO:0071800) |
0.1 | 0.6 | GO:0006465 | signal peptide processing(GO:0006465) |
0.1 | 0.8 | GO:0008380 | RNA splicing(GO:0008380) |
0.1 | 0.2 | GO:0045759 | negative regulation of action potential(GO:0045759) |
0.1 | 0.5 | GO:0035116 | embryonic hindlimb morphogenesis(GO:0035116) |
0.1 | 0.8 | GO:0006402 | mRNA catabolic process(GO:0006402) |
0.1 | 0.2 | GO:0033619 | membrane protein proteolysis(GO:0033619) |
0.1 | 0.2 | GO:0032418 | lysosome localization(GO:0032418) |
0.1 | 0.2 | GO:0060992 | response to fungicide(GO:0060992) |
0.1 | 1.3 | GO:0007257 | activation of JUN kinase activity(GO:0007257) |
0.1 | 0.4 | GO:0016125 | sterol metabolic process(GO:0016125) |
0.1 | 0.1 | GO:0060620 | regulation of cholesterol import(GO:0060620) regulation of sterol import(GO:2000909) |
0.1 | 0.9 | GO:0045576 | mast cell activation(GO:0045576) |
0.1 | 0.3 | GO:0008535 | respiratory chain complex IV assembly(GO:0008535) |
0.1 | 0.3 | GO:0051567 | histone H3-K9 methylation(GO:0051567) histone H3-K9 modification(GO:0061647) |
0.1 | 5.4 | GO:0018279 | peptidyl-asparagine modification(GO:0018196) protein N-linked glycosylation via asparagine(GO:0018279) |
0.1 | 0.5 | GO:0033687 | osteoblast proliferation(GO:0033687) |
0.1 | 2.6 | GO:0006635 | fatty acid beta-oxidation(GO:0006635) |
0.1 | 0.1 | GO:0034287 | detection of carbohydrate stimulus(GO:0009730) detection of hexose stimulus(GO:0009732) detection of monosaccharide stimulus(GO:0034287) detection of glucose(GO:0051594) |
0.1 | 0.1 | GO:0002244 | hematopoietic progenitor cell differentiation(GO:0002244) |
0.1 | 0.2 | GO:0042226 | interleukin-6 biosynthetic process(GO:0042226) |
0.1 | 0.3 | GO:0035335 | peptidyl-tyrosine dephosphorylation(GO:0035335) |
0.1 | 0.3 | GO:0042416 | dopamine biosynthetic process(GO:0042416) |
0.1 | 0.4 | GO:0006312 | mitotic recombination(GO:0006312) |
0.1 | 0.1 | GO:0035315 | hair cell differentiation(GO:0035315) |
0.1 | 14.5 | GO:0006397 | mRNA processing(GO:0006397) |
0.1 | 0.1 | GO:0051383 | kinetochore organization(GO:0051383) |
0.1 | 0.4 | GO:0010039 | response to iron ion(GO:0010039) |
0.1 | 0.4 | GO:0071157 | negative regulation of cell cycle arrest(GO:0071157) |
0.1 | 0.1 | GO:0001661 | conditioned taste aversion(GO:0001661) |
0.1 | 3.1 | GO:0006413 | translational initiation(GO:0006413) |
0.1 | 0.2 | GO:0033158 | regulation of protein import into nucleus, translocation(GO:0033158) |
0.1 | 0.1 | GO:0051123 | RNA polymerase II transcriptional preinitiation complex assembly(GO:0051123) DNA-templated transcriptional preinitiation complex assembly(GO:0070897) |
0.1 | 14.5 | GO:0016568 | chromatin modification(GO:0016568) |
0.1 | 0.1 | GO:0010165 | response to X-ray(GO:0010165) |
0.1 | 0.1 | GO:0010447 | response to acidic pH(GO:0010447) |
0.1 | 0.4 | GO:0003084 | positive regulation of systemic arterial blood pressure(GO:0003084) |
0.1 | 0.4 | GO:0051189 | Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) molybdopterin cofactor biosynthetic process(GO:0032324) molybdopterin cofactor metabolic process(GO:0043545) prosthetic group metabolic process(GO:0051189) |
0.1 | 0.3 | GO:0045040 | outer mitochondrial membrane organization(GO:0007008) protein import into mitochondrial outer membrane(GO:0045040) |
0.1 | 4.9 | GO:0022900 | electron transport chain(GO:0022900) |
0.1 | 0.6 | GO:0009812 | flavonoid metabolic process(GO:0009812) |
0.1 | 0.3 | GO:0007530 | sex determination(GO:0007530) |
0.1 | 0.1 | GO:0042523 | tyrosine phosphorylation of Stat5 protein(GO:0042506) regulation of tyrosine phosphorylation of Stat5 protein(GO:0042522) positive regulation of tyrosine phosphorylation of Stat5 protein(GO:0042523) |
0.1 | 0.1 | GO:0071320 | cellular response to cAMP(GO:0071320) |
0.1 | 0.1 | GO:0019276 | UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
0.1 | 0.3 | GO:0042098 | T cell proliferation(GO:0042098) |
0.1 | 0.1 | GO:0046666 | retinal cell programmed cell death(GO:0046666) |
0.1 | 0.6 | GO:0045351 | type I interferon biosynthetic process(GO:0045351) |
0.1 | 0.1 | GO:0071277 | cellular response to calcium ion(GO:0071277) |
0.1 | 0.9 | GO:0000080 | mitotic G1 phase(GO:0000080) |
0.1 | 0.2 | GO:0006108 | malate metabolic process(GO:0006108) |
0.1 | 2.8 | GO:0006968 | cellular defense response(GO:0006968) |
0.1 | 0.2 | GO:0097031 | NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
0.1 | 0.3 | GO:0042771 | intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:0042771) |
0.1 | 0.1 | GO:0003057 | regulation of the force of heart contraction by chemical signal(GO:0003057) |
0.1 | 0.1 | GO:0002862 | negative regulation of inflammatory response to antigenic stimulus(GO:0002862) |
0.1 | 0.3 | GO:0030903 | notochord development(GO:0030903) |
0.1 | 0.2 | GO:0042178 | xenobiotic catabolic process(GO:0042178) |
0.1 | 0.6 | GO:0015693 | magnesium ion transport(GO:0015693) |
0.1 | 0.2 | GO:0045767 | obsolete regulation of anti-apoptosis(GO:0045767) |
0.1 | 0.2 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
0.1 | 0.8 | GO:0006613 | cotranslational protein targeting to membrane(GO:0006613) |
0.1 | 0.7 | GO:0016180 | snRNA processing(GO:0016180) |
0.1 | 0.1 | GO:0072033 | renal vesicle formation(GO:0072033) |
0.1 | 1.4 | GO:0046847 | filopodium assembly(GO:0046847) |
0.1 | 0.1 | GO:0033600 | negative regulation of mammary gland epithelial cell proliferation(GO:0033600) |
0.1 | 0.2 | GO:0032364 | oxygen homeostasis(GO:0032364) |
0.1 | 0.5 | GO:0045022 | early endosome to late endosome transport(GO:0045022) vesicle-mediated transport between endosomal compartments(GO:0098927) |
0.1 | 0.1 | GO:0009698 | phenylpropanoid metabolic process(GO:0009698) coumarin metabolic process(GO:0009804) |
0.1 | 0.3 | GO:0009303 | rRNA transcription(GO:0009303) |
0.1 | 0.1 | GO:0045670 | regulation of osteoclast differentiation(GO:0045670) |
0.1 | 0.1 | GO:0006482 | protein demethylation(GO:0006482) protein dealkylation(GO:0008214) |
0.1 | 0.2 | GO:0060285 | cilium-dependent cell motility(GO:0060285) |
0.1 | 0.2 | GO:0016264 | gap junction assembly(GO:0016264) |
0.1 | 0.2 | GO:0016071 | mRNA metabolic process(GO:0016071) |
0.1 | 0.5 | GO:0016226 | iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
0.1 | 0.1 | GO:0045603 | positive regulation of endothelial cell differentiation(GO:0045603) |
0.1 | 0.3 | GO:0046513 | ceramide biosynthetic process(GO:0046513) |
0.1 | 0.7 | GO:0071577 | zinc II ion transmembrane transport(GO:0071577) |
0.1 | 0.3 | GO:0032836 | glomerular basement membrane development(GO:0032836) |
0.1 | 0.1 | GO:0051016 | barbed-end actin filament capping(GO:0051016) |
0.1 | 0.3 | GO:0042535 | positive regulation of tumor necrosis factor biosynthetic process(GO:0042535) |
0.1 | 0.1 | GO:0006681 | galactosylceramide metabolic process(GO:0006681) |
0.1 | 0.1 | GO:0045717 | negative regulation of fatty acid biosynthetic process(GO:0045717) |
0.1 | 0.1 | GO:0016048 | detection of temperature stimulus(GO:0016048) detection of temperature stimulus involved in sensory perception(GO:0050961) detection of temperature stimulus involved in sensory perception of pain(GO:0050965) |
0.1 | 0.3 | GO:0035329 | hippo signaling(GO:0035329) |
0.1 | 0.9 | GO:0006783 | heme biosynthetic process(GO:0006783) |
0.1 | 0.5 | GO:0046677 | response to antibiotic(GO:0046677) |
0.1 | 1.2 | GO:0006706 | steroid catabolic process(GO:0006706) |
0.1 | 0.1 | GO:0000076 | DNA replication checkpoint(GO:0000076) |
0.1 | 0.4 | GO:0007141 | male meiosis I(GO:0007141) |
0.1 | 0.4 | GO:0043523 | regulation of neuron apoptotic process(GO:0043523) regulation of neuron death(GO:1901214) |
0.1 | 0.2 | GO:0021615 | glossopharyngeal nerve development(GO:0021563) glossopharyngeal nerve morphogenesis(GO:0021615) |
0.1 | 0.6 | GO:0006297 | nucleotide-excision repair, DNA gap filling(GO:0006297) |
0.1 | 0.1 | GO:0060317 | cardiac epithelial to mesenchymal transition(GO:0060317) |
0.1 | 0.1 | GO:0018344 | protein geranylgeranylation(GO:0018344) |
0.1 | 1.8 | GO:0030521 | androgen receptor signaling pathway(GO:0030521) |
0.1 | 1.3 | GO:0006506 | GPI anchor biosynthetic process(GO:0006506) |
0.1 | 0.6 | GO:0007020 | microtubule nucleation(GO:0007020) |
0.1 | 0.2 | GO:0006855 | drug transmembrane transport(GO:0006855) |
0.1 | 2.2 | GO:0000236 | mitotic prometaphase(GO:0000236) |
0.1 | 0.3 | GO:0010212 | response to ionizing radiation(GO:0010212) |
0.1 | 0.7 | GO:0006044 | N-acetylglucosamine metabolic process(GO:0006044) |
0.1 | 0.1 | GO:0010595 | positive regulation of endothelial cell migration(GO:0010595) |
0.1 | 0.2 | GO:0045671 | negative regulation of osteoclast differentiation(GO:0045671) |
0.1 | 0.5 | GO:0031334 | positive regulation of protein complex assembly(GO:0031334) |
0.1 | 0.2 | GO:0000060 | protein import into nucleus, translocation(GO:0000060) |
0.1 | 0.3 | GO:0060040 | retinal bipolar neuron differentiation(GO:0060040) |
0.1 | 0.1 | GO:0009649 | entrainment of circadian clock(GO:0009649) |
0.1 | 0.3 | GO:0006152 | purine nucleoside catabolic process(GO:0006152) purine ribonucleoside catabolic process(GO:0046130) |
0.1 | 0.2 | GO:0008291 | acetylcholine metabolic process(GO:0008291) acetate ester metabolic process(GO:1900619) |
0.1 | 0.3 | GO:0006685 | sphingomyelin catabolic process(GO:0006685) |
0.1 | 0.1 | GO:0001709 | cell fate determination(GO:0001709) |
0.1 | 4.5 | GO:0006333 | chromatin assembly or disassembly(GO:0006333) |
0.1 | 0.1 | GO:0072498 | embryonic skeletal joint morphogenesis(GO:0060272) embryonic skeletal joint development(GO:0072498) |
0.1 | 0.7 | GO:0000045 | autophagosome assembly(GO:0000045) autophagosome organization(GO:1905037) |
0.1 | 0.2 | GO:0032401 | establishment of melanosome localization(GO:0032401) |
0.1 | 0.1 | GO:0018343 | protein farnesylation(GO:0018343) |
0.1 | 0.3 | GO:0002286 | T cell activation involved in immune response(GO:0002286) |
0.1 | 4.3 | GO:0006364 | rRNA processing(GO:0006364) |
0.1 | 1.3 | GO:0034976 | response to endoplasmic reticulum stress(GO:0034976) |
0.1 | 1.0 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
0.1 | 0.2 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
0.1 | 0.1 | GO:0071354 | cellular response to interleukin-6(GO:0071354) |
0.1 | 0.9 | GO:0022406 | membrane docking(GO:0022406) |
0.1 | 0.1 | GO:0010310 | regulation of hydrogen peroxide metabolic process(GO:0010310) |
0.1 | 0.2 | GO:0051182 | coenzyme transport(GO:0051182) |
0.1 | 0.1 | GO:0048537 | mucosal-associated lymphoid tissue development(GO:0048537) |
0.1 | 0.1 | GO:0002495 | antigen processing and presentation of peptide antigen via MHC class II(GO:0002495) |
0.1 | 0.1 | GO:0060707 | trophoblast giant cell differentiation(GO:0060707) |
0.1 | 0.1 | GO:0070534 | protein K63-linked ubiquitination(GO:0070534) |
0.1 | 0.2 | GO:0014904 | myotube cell development(GO:0014904) skeletal muscle fiber development(GO:0048741) |
0.1 | 0.4 | GO:0006103 | 2-oxoglutarate metabolic process(GO:0006103) |
0.1 | 0.1 | GO:0035234 | ectopic germ cell programmed cell death(GO:0035234) |
0.1 | 0.6 | GO:0019221 | cytokine-mediated signaling pathway(GO:0019221) |
0.1 | 1.2 | GO:0006691 | leukotriene metabolic process(GO:0006691) |
0.1 | 0.1 | GO:0019042 | viral latency(GO:0019042) |
0.1 | 0.1 | GO:0048892 | sensory system development(GO:0048880) lateral line nerve development(GO:0048892) lateral line nerve glial cell differentiation(GO:0048895) lateral line system development(GO:0048925) lateral line nerve glial cell development(GO:0048937) iridophore differentiation(GO:0050935) |
0.1 | 0.1 | GO:0032715 | negative regulation of interleukin-6 production(GO:0032715) |
0.1 | 0.3 | GO:0050957 | equilibrioception(GO:0050957) |
0.1 | 0.1 | GO:0032926 | negative regulation of activin receptor signaling pathway(GO:0032926) |
0.1 | 0.1 | GO:0002085 | inhibition of neuroepithelial cell differentiation(GO:0002085) |
0.1 | 0.6 | GO:0015939 | pantothenate metabolic process(GO:0015939) |
0.1 | 0.6 | GO:0030513 | positive regulation of BMP signaling pathway(GO:0030513) |
0.1 | 0.3 | GO:0006102 | isocitrate metabolic process(GO:0006102) |
0.1 | 0.2 | GO:0032957 | inositol trisphosphate metabolic process(GO:0032957) |
0.1 | 0.1 | GO:1903580 | positive regulation of nucleotide catabolic process(GO:0030813) positive regulation of glycolytic process(GO:0045821) positive regulation of nucleoside metabolic process(GO:0045979) positive regulation of cofactor metabolic process(GO:0051194) positive regulation of coenzyme metabolic process(GO:0051197) positive regulation of ATP metabolic process(GO:1903580) |
0.1 | 0.1 | GO:0042819 | pyridoxine metabolic process(GO:0008614) pyridoxine biosynthetic process(GO:0008615) vitamin B6 metabolic process(GO:0042816) vitamin B6 biosynthetic process(GO:0042819) |
0.1 | 0.3 | GO:0042982 | amyloid precursor protein metabolic process(GO:0042982) |
0.1 | 0.2 | GO:0030183 | B cell differentiation(GO:0030183) |
0.1 | 0.2 | GO:0008105 | asymmetric protein localization(GO:0008105) |
0.1 | 0.2 | GO:0007093 | mitotic cell cycle checkpoint(GO:0007093) |
0.1 | 0.1 | GO:0045654 | positive regulation of megakaryocyte differentiation(GO:0045654) positive regulation of hematopoietic progenitor cell differentiation(GO:1901534) |
0.1 | 0.4 | GO:0005513 | detection of calcium ion(GO:0005513) |
0.1 | 0.1 | GO:0045943 | positive regulation of transcription from RNA polymerase I promoter(GO:0045943) |
0.1 | 0.1 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
0.1 | 0.5 | GO:1901663 | quinone biosynthetic process(GO:1901663) |
0.1 | 0.1 | GO:0042695 | thelarche(GO:0042695) mammary gland branching involved in thelarche(GO:0060744) |
0.1 | 0.2 | GO:0032543 | mitochondrial translation(GO:0032543) |
0.1 | 0.7 | GO:0046834 | lipid phosphorylation(GO:0046834) |
0.1 | 0.1 | GO:0032905 | transforming growth factor beta1 production(GO:0032905) regulation of transforming growth factor beta1 production(GO:0032908) positive regulation of transforming growth factor beta1 production(GO:0032914) |
0.1 | 0.1 | GO:0050851 | antigen receptor-mediated signaling pathway(GO:0050851) |
0.1 | 0.3 | GO:0030520 | intracellular estrogen receptor signaling pathway(GO:0030520) |
0.1 | 0.2 | GO:0006787 | porphyrin-containing compound catabolic process(GO:0006787) tetrapyrrole catabolic process(GO:0033015) heme catabolic process(GO:0042167) pigment catabolic process(GO:0046149) |
0.1 | 0.1 | GO:0043248 | proteasome assembly(GO:0043248) |
0.1 | 0.4 | GO:0030071 | regulation of mitotic metaphase/anaphase transition(GO:0030071) regulation of metaphase/anaphase transition of cell cycle(GO:1902099) |
0.1 | 0.3 | GO:0000087 | mitotic M phase(GO:0000087) |
0.1 | 0.1 | GO:0048016 | inositol phosphate-mediated signaling(GO:0048016) |
0.1 | 0.1 | GO:0060897 | neural plate anterior/posterior regionalization(GO:0021999) neural plate regionalization(GO:0060897) |
0.1 | 0.1 | GO:0060298 | positive regulation of sarcomere organization(GO:0060298) |
0.1 | 0.1 | GO:0060684 | epithelial-mesenchymal cell signaling(GO:0060684) |
0.1 | 0.1 | GO:0002092 | positive regulation of receptor internalization(GO:0002092) |
0.1 | 0.1 | GO:0010952 | positive regulation of peptidase activity(GO:0010952) |
0.1 | 0.1 | GO:0003254 | regulation of membrane depolarization(GO:0003254) |
0.1 | 0.1 | GO:0019883 | antigen processing and presentation of endogenous antigen(GO:0019883) |
0.1 | 0.1 | GO:0002823 | negative regulation of adaptive immune response(GO:0002820) negative regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains(GO:0002823) |
0.1 | 0.2 | GO:0006862 | nucleotide transport(GO:0006862) |
0.1 | 0.1 | GO:0045672 | positive regulation of osteoclast differentiation(GO:0045672) |
0.1 | 0.1 | GO:0002002 | regulation of angiotensin levels in blood(GO:0002002) |
0.1 | 0.1 | GO:0048268 | clathrin coat assembly(GO:0048268) |
0.1 | 0.1 | GO:0005984 | disaccharide metabolic process(GO:0005984) |
0.1 | 0.2 | GO:0090195 | chemokine secretion(GO:0090195) regulation of chemokine secretion(GO:0090196) positive regulation of chemokine secretion(GO:0090197) |
0.1 | 0.4 | GO:0051457 | maintenance of protein location in nucleus(GO:0051457) |
0.1 | 0.2 | GO:0021533 | cell differentiation in hindbrain(GO:0021533) |
0.1 | 0.3 | GO:0001514 | selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
0.1 | 0.2 | GO:0071392 | cellular response to estradiol stimulus(GO:0071392) |
0.1 | 0.3 | GO:0015886 | heme transport(GO:0015886) |
0.1 | 0.3 | GO:0000050 | urea cycle(GO:0000050) |
0.1 | 0.3 | GO:0045745 | positive regulation of G-protein coupled receptor protein signaling pathway(GO:0045745) |
0.1 | 0.6 | GO:0007030 | Golgi organization(GO:0007030) |
0.1 | 0.1 | GO:0060662 | tube lumen cavitation(GO:0060605) salivary gland cavitation(GO:0060662) |
0.1 | 1.4 | GO:0042254 | ribosome biogenesis(GO:0042254) |
0.1 | 0.1 | GO:0001708 | cell fate specification(GO:0001708) |
0.1 | 0.2 | GO:0002200 | somatic diversification of immune receptors(GO:0002200) |
0.1 | 0.2 | GO:0031529 | ruffle organization(GO:0031529) |
0.1 | 0.1 | GO:0070172 | positive regulation of tooth mineralization(GO:0070172) |
0.1 | 0.3 | GO:0046348 | chitin metabolic process(GO:0006030) chitin catabolic process(GO:0006032) amino sugar catabolic process(GO:0046348) glucosamine-containing compound catabolic process(GO:1901072) |
0.1 | 0.1 | GO:0048808 | male genitalia morphogenesis(GO:0048808) male anatomical structure morphogenesis(GO:0090598) |
0.1 | 0.1 | GO:0045047 | protein targeting to ER(GO:0045047) establishment of protein localization to endoplasmic reticulum(GO:0072599) |
0.1 | 0.3 | GO:0034030 | nucleoside bisphosphate biosynthetic process(GO:0033866) ribonucleoside bisphosphate biosynthetic process(GO:0034030) purine nucleoside bisphosphate biosynthetic process(GO:0034033) |
0.1 | 0.1 | GO:0031669 | cellular response to nutrient levels(GO:0031669) |
0.0 | 0.1 | GO:0007035 | vacuolar acidification(GO:0007035) |
0.0 | 0.4 | GO:0030212 | hyaluronan metabolic process(GO:0030212) |
0.0 | 0.4 | GO:0007270 | neuron-neuron synaptic transmission(GO:0007270) |
0.0 | 0.1 | GO:0007271 | synaptic transmission, cholinergic(GO:0007271) |
0.0 | 0.1 | GO:0060017 | parathyroid gland development(GO:0060017) |
0.0 | 1.1 | GO:0015807 | L-amino acid transport(GO:0015807) |
0.0 | 0.6 | GO:0010043 | response to zinc ion(GO:0010043) |
0.0 | 0.0 | GO:0032757 | positive regulation of interleukin-8 production(GO:0032757) |
0.0 | 0.1 | GO:0071542 | dopaminergic neuron differentiation(GO:0071542) |
0.0 | 12.0 | GO:0006412 | translation(GO:0006412) |
0.0 | 0.0 | GO:0009215 | purine deoxyribonucleoside triphosphate metabolic process(GO:0009215) |
0.0 | 0.0 | GO:0033151 | V(D)J recombination(GO:0033151) |
0.0 | 0.2 | GO:0051026 | chiasma assembly(GO:0051026) |
0.0 | 0.3 | GO:0021515 | cell differentiation in spinal cord(GO:0021515) |
0.0 | 0.0 | GO:0042420 | dopamine catabolic process(GO:0042420) |
0.0 | 0.0 | GO:0009313 | oligosaccharide catabolic process(GO:0009313) |
0.0 | 0.1 | GO:0030263 | apoptotic chromosome condensation(GO:0030263) |
0.0 | 0.0 | GO:0010890 | positive regulation of sequestering of triglyceride(GO:0010890) |
0.0 | 0.1 | GO:0003341 | cilium movement(GO:0003341) |
0.0 | 0.4 | GO:0008637 | apoptotic mitochondrial changes(GO:0008637) |
0.0 | 0.0 | GO:0060896 | neural plate pattern specification(GO:0060896) |
0.0 | 0.1 | GO:1903320 | regulation of protein modification by small protein conjugation or removal(GO:1903320) |
0.0 | 0.1 | GO:0060712 | spongiotrophoblast layer development(GO:0060712) |
0.0 | 0.1 | GO:0034755 | iron ion transmembrane transport(GO:0034755) |
0.0 | 0.0 | GO:0002125 | maternal aggressive behavior(GO:0002125) |
0.0 | 0.1 | GO:0006659 | phosphatidylserine biosynthetic process(GO:0006659) |
0.0 | 0.3 | GO:0042994 | cytoplasmic sequestering of transcription factor(GO:0042994) |
0.0 | 0.1 | GO:0032069 | regulation of nuclease activity(GO:0032069) |
0.0 | 0.1 | GO:0043049 | otic placode formation(GO:0043049) |
0.0 | 0.2 | GO:0060023 | soft palate development(GO:0060023) |
0.0 | 0.6 | GO:0006959 | humoral immune response(GO:0006959) |
0.0 | 0.0 | GO:0051881 | regulation of mitochondrial membrane potential(GO:0051881) |
0.0 | 0.6 | GO:0008299 | isoprenoid biosynthetic process(GO:0008299) |
0.0 | 0.3 | GO:0051238 | sequestering of metal ion(GO:0051238) |
0.0 | 0.1 | GO:0046877 | regulation of saliva secretion(GO:0046877) |
0.0 | 0.2 | GO:0006607 | NLS-bearing protein import into nucleus(GO:0006607) |
0.0 | 0.1 | GO:0033147 | negative regulation of intracellular estrogen receptor signaling pathway(GO:0033147) |
0.0 | 0.1 | GO:0008635 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c(GO:0008635) |
0.0 | 0.1 | GO:0051647 | nucleus localization(GO:0051647) |
0.0 | 0.1 | GO:0048291 | isotype switching to IgG isotypes(GO:0048291) |
0.0 | 0.2 | GO:0008343 | adult feeding behavior(GO:0008343) |
0.0 | 0.1 | GO:0050847 | progesterone receptor signaling pathway(GO:0050847) |
0.0 | 0.1 | GO:0051402 | neuron apoptotic process(GO:0051402) |
0.0 | 0.1 | GO:0048535 | lymph node development(GO:0048535) |
0.0 | 0.1 | GO:1903299 | regulation of glucokinase activity(GO:0033131) positive regulation of glucokinase activity(GO:0033133) regulation of hexokinase activity(GO:1903299) positive regulation of hexokinase activity(GO:1903301) |
0.0 | 0.1 | GO:0051788 | response to misfolded protein(GO:0051788) |
0.0 | 0.1 | GO:0045743 | positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
0.0 | 0.2 | GO:1901661 | quinone metabolic process(GO:1901661) |
0.0 | 0.0 | GO:0032494 | response to peptidoglycan(GO:0032494) |
0.0 | 0.5 | GO:0043252 | sodium-independent organic anion transport(GO:0043252) |
0.0 | 1.2 | GO:0006986 | response to unfolded protein(GO:0006986) |
0.0 | 0.2 | GO:0046655 | folic acid metabolic process(GO:0046655) |
0.0 | 0.0 | GO:0010458 | exit from mitosis(GO:0010458) |
0.0 | 0.3 | GO:0061572 | actin filament bundle assembly(GO:0051017) actin filament bundle organization(GO:0061572) |
0.0 | 0.2 | GO:0010288 | response to lead ion(GO:0010288) |
0.0 | 0.1 | GO:0001778 | plasma membrane repair(GO:0001778) |
0.0 | 0.1 | GO:0009113 | purine nucleobase biosynthetic process(GO:0009113) |
0.0 | 0.6 | GO:0032480 | negative regulation of type I interferon production(GO:0032480) |
0.0 | 0.3 | GO:0051607 | defense response to virus(GO:0051607) |
0.0 | 0.1 | GO:0045911 | positive regulation of DNA recombination(GO:0045911) |
0.0 | 0.1 | GO:0032227 | negative regulation of synaptic transmission, dopaminergic(GO:0032227) |
0.0 | 0.1 | GO:0043649 | dicarboxylic acid catabolic process(GO:0043649) |
0.0 | 0.1 | GO:1903729 | regulation of plasma membrane organization(GO:1903729) |
0.0 | 0.2 | GO:0000018 | regulation of DNA recombination(GO:0000018) |
0.0 | 0.2 | GO:0021610 | facial nerve development(GO:0021561) cranial nerve structural organization(GO:0021604) facial nerve morphogenesis(GO:0021610) facial nerve structural organization(GO:0021612) anatomical structure arrangement(GO:0048532) |
0.0 | 0.1 | GO:0006984 | ER-nucleus signaling pathway(GO:0006984) |
0.0 | 0.0 | GO:0002025 | vasodilation by norepinephrine-epinephrine involved in regulation of systemic arterial blood pressure(GO:0002025) desensitization of G-protein coupled receptor protein signaling pathway by arrestin(GO:0002032) |
0.0 | 0.0 | GO:0021859 | pyramidal neuron differentiation(GO:0021859) pyramidal neuron development(GO:0021860) |
0.0 | 0.1 | GO:0035095 | behavioral response to nicotine(GO:0035095) |
0.0 | 0.1 | GO:0042415 | norepinephrine metabolic process(GO:0042415) |
0.0 | 0.3 | GO:0006099 | tricarboxylic acid cycle(GO:0006099) |
0.0 | 0.0 | GO:0006545 | glycine biosynthetic process(GO:0006545) |
0.0 | 0.0 | GO:0003077 | obsolete negative regulation of diuresis(GO:0003077) |
0.0 | 1.5 | GO:0034339 | obsolete regulation of transcription from RNA polymerase II promoter by nuclear hormone receptor(GO:0034339) |
0.0 | 4.6 | GO:0043087 | regulation of GTPase activity(GO:0043087) |
0.0 | 0.1 | GO:0098763 | mitotic cell cycle phase(GO:0098763) |
0.0 | 0.1 | GO:0003100 | regulation of systemic arterial blood pressure by endothelin(GO:0003100) |
0.0 | 0.1 | GO:0060236 | regulation of mitotic spindle organization(GO:0060236) regulation of spindle organization(GO:0090224) |
0.0 | 0.1 | GO:0048496 | maintenance of organ identity(GO:0048496) |
0.0 | 0.2 | GO:0034375 | high-density lipoprotein particle remodeling(GO:0034375) |
0.0 | 0.1 | GO:0015864 | pyrimidine nucleoside transport(GO:0015864) |
0.0 | 0.3 | GO:0034101 | erythrocyte homeostasis(GO:0034101) |
0.0 | 0.2 | GO:0032731 | positive regulation of interleukin-1 beta production(GO:0032731) |
0.0 | 0.1 | GO:0032927 | positive regulation of activin receptor signaling pathway(GO:0032927) |
0.0 | 0.0 | GO:0007506 | gonadal mesoderm development(GO:0007506) |
0.0 | 0.1 | GO:0071378 | growth hormone receptor signaling pathway(GO:0060396) cellular response to growth hormone stimulus(GO:0071378) |
0.0 | 0.3 | GO:0030326 | embryonic limb morphogenesis(GO:0030326) embryonic appendage morphogenesis(GO:0035113) |
0.0 | 0.3 | GO:0006903 | vesicle targeting(GO:0006903) |
0.0 | 0.2 | GO:0030099 | myeloid cell differentiation(GO:0030099) |
0.0 | 0.2 | GO:0050910 | detection of mechanical stimulus involved in sensory perception of sound(GO:0050910) |
0.0 | 0.6 | GO:0006400 | tRNA modification(GO:0006400) |
0.0 | 0.0 | GO:0002449 | lymphocyte mediated immunity(GO:0002449) |
0.0 | 0.0 | GO:0050702 | interleukin-1 beta secretion(GO:0050702) |
0.0 | 0.1 | GO:0045601 | regulation of endothelial cell differentiation(GO:0045601) |
0.0 | 0.2 | GO:0045806 | negative regulation of endocytosis(GO:0045806) |
0.0 | 0.0 | GO:0032613 | interleukin-10 production(GO:0032613) |
0.0 | 0.0 | GO:0070228 | regulation of lymphocyte apoptotic process(GO:0070228) |
0.0 | 0.2 | GO:0051928 | positive regulation of calcium ion transport(GO:0051928) |
0.0 | 1.6 | GO:0034470 | ncRNA processing(GO:0034470) |
0.0 | 0.2 | GO:0032007 | negative regulation of TOR signaling(GO:0032007) |
0.0 | 0.1 | GO:0070493 | thrombin receptor signaling pathway(GO:0070493) |
0.0 | 0.2 | GO:0015893 | drug transport(GO:0015893) |
0.0 | 0.1 | GO:0021781 | glial cell fate commitment(GO:0021781) |
0.0 | 0.0 | GO:0051445 | regulation of meiotic nuclear division(GO:0040020) regulation of meiotic cell cycle(GO:0051445) |
0.0 | 0.1 | GO:0019509 | L-methionine biosynthetic process from methylthioadenosine(GO:0019509) |
0.0 | 0.0 | GO:0043171 | peptide catabolic process(GO:0043171) |
0.0 | 0.0 | GO:0051057 | positive regulation of small GTPase mediated signal transduction(GO:0051057) |
0.0 | 0.0 | GO:0032528 | microvillus assembly(GO:0030033) microvillus organization(GO:0032528) |
0.0 | 0.1 | GO:0021511 | spinal cord patterning(GO:0021511) |
0.0 | 0.0 | GO:0071470 | cellular response to osmotic stress(GO:0071470) |
0.0 | 0.4 | GO:0006699 | bile acid biosynthetic process(GO:0006699) |
0.0 | 0.7 | GO:0046777 | protein autophosphorylation(GO:0046777) |
0.0 | 0.3 | GO:0033574 | response to testosterone(GO:0033574) |
0.0 | 0.7 | GO:0035337 | fatty-acyl-CoA metabolic process(GO:0035337) fatty-acyl-CoA biosynthetic process(GO:0046949) |
0.0 | 0.2 | GO:0045930 | negative regulation of mitotic cell cycle(GO:0045930) |
0.0 | 0.2 | GO:0051654 | establishment of mitochondrion localization(GO:0051654) |
0.0 | 0.1 | GO:0009173 | UMP biosynthetic process(GO:0006222) pyrimidine ribonucleoside monophosphate metabolic process(GO:0009173) pyrimidine ribonucleoside monophosphate biosynthetic process(GO:0009174) UMP metabolic process(GO:0046049) |
0.0 | 0.1 | GO:1902622 | regulation of neutrophil chemotaxis(GO:0090022) regulation of neutrophil migration(GO:1902622) |
0.0 | 0.6 | GO:0007339 | binding of sperm to zona pellucida(GO:0007339) |
0.0 | 0.2 | GO:0006555 | methionine metabolic process(GO:0006555) |
0.0 | 0.1 | GO:0019532 | oxalate transport(GO:0019532) |
0.0 | 0.4 | GO:0006401 | RNA catabolic process(GO:0006401) |
0.0 | 0.1 | GO:0045909 | positive regulation of vasodilation(GO:0045909) |
0.0 | 0.3 | GO:0006306 | DNA alkylation(GO:0006305) DNA methylation(GO:0006306) |
0.0 | 0.8 | GO:0006909 | phagocytosis(GO:0006909) |
0.0 | 0.0 | GO:0003339 | regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis(GO:0003339) |
0.0 | 0.0 | GO:0032490 | detection of molecule of bacterial origin(GO:0032490) |
0.0 | 0.1 | GO:0006308 | DNA catabolic process(GO:0006308) |
0.0 | 0.9 | GO:0006368 | transcription elongation from RNA polymerase II promoter(GO:0006368) |
0.0 | 0.7 | GO:0000186 | activation of MAPKK activity(GO:0000186) |
0.0 | 0.1 | GO:0006700 | C21-steroid hormone biosynthetic process(GO:0006700) C21-steroid hormone metabolic process(GO:0008207) |
0.0 | 0.0 | GO:0032210 | regulation of telomere maintenance via telomerase(GO:0032210) |
0.0 | 0.6 | GO:0071377 | cellular response to glucagon stimulus(GO:0071377) |
0.0 | 0.0 | GO:0022038 | corpus callosum development(GO:0022038) |
0.0 | 0.1 | GO:0042503 | tyrosine phosphorylation of Stat3 protein(GO:0042503) |
0.0 | 0.3 | GO:0007190 | activation of adenylate cyclase activity(GO:0007190) |
0.0 | 0.0 | GO:0007144 | female meiosis I(GO:0007144) |
0.0 | 0.0 | GO:0034371 | chylomicron remodeling(GO:0034371) |
0.0 | 0.1 | GO:0060412 | ventricular septum morphogenesis(GO:0060412) |
0.0 | 0.4 | GO:0032434 | regulation of proteasomal ubiquitin-dependent protein catabolic process(GO:0032434) |
0.0 | 0.0 | GO:0000266 | mitochondrial fission(GO:0000266) |
0.0 | 2.4 | GO:0007249 | I-kappaB kinase/NF-kappaB signaling(GO:0007249) |
0.0 | 0.3 | GO:0019933 | cAMP-mediated signaling(GO:0019933) |
0.0 | 0.0 | GO:0042424 | phenol-containing compound catabolic process(GO:0019336) catechol-containing compound catabolic process(GO:0019614) catecholamine catabolic process(GO:0042424) |
0.0 | 0.1 | GO:0021978 | telencephalon regionalization(GO:0021978) |
0.0 | 0.9 | GO:0042059 | negative regulation of epidermal growth factor receptor signaling pathway(GO:0042059) negative regulation of ERBB signaling pathway(GO:1901185) |
0.0 | 0.0 | GO:0001554 | luteolysis(GO:0001554) |
0.0 | 0.1 | GO:0070647 | protein modification by small protein conjugation or removal(GO:0070647) |
0.0 | 0.2 | GO:0007045 | cell-substrate adherens junction assembly(GO:0007045) focal adhesion assembly(GO:0048041) |
0.0 | 0.1 | GO:0016265 | obsolete death(GO:0016265) |
0.0 | 0.1 | GO:2000573 | positive regulation of DNA biosynthetic process(GO:2000573) |
0.0 | 0.1 | GO:0018107 | peptidyl-threonine phosphorylation(GO:0018107) |
0.0 | 0.1 | GO:0001938 | positive regulation of endothelial cell proliferation(GO:0001938) |
0.0 | 0.1 | GO:1903037 | regulation of T cell activation(GO:0050863) regulation of leukocyte cell-cell adhesion(GO:1903037) |
0.0 | 0.3 | GO:0003407 | neural retina development(GO:0003407) |
0.0 | 0.1 | GO:0006354 | DNA-templated transcription, elongation(GO:0006354) |
0.0 | 0.1 | GO:0008213 | protein methylation(GO:0006479) protein alkylation(GO:0008213) |
0.0 | 0.3 | GO:0002696 | positive regulation of leukocyte activation(GO:0002696) |
0.0 | 0.1 | GO:0033631 | cell-cell adhesion mediated by integrin(GO:0033631) |
0.0 | 0.4 | GO:0051899 | membrane depolarization(GO:0051899) |
0.0 | 0.1 | GO:0034382 | chylomicron remnant clearance(GO:0034382) triglyceride-rich lipoprotein particle clearance(GO:0071830) |
0.0 | 0.2 | GO:0006729 | tetrahydrobiopterin biosynthetic process(GO:0006729) |
0.0 | 0.2 | GO:0006528 | asparagine metabolic process(GO:0006528) |
0.0 | 0.2 | GO:0031647 | regulation of protein stability(GO:0031647) |
0.0 | 0.1 | GO:0010155 | regulation of proton transport(GO:0010155) |
0.0 | 0.1 | GO:0015742 | alpha-ketoglutarate transport(GO:0015742) |
0.0 | 0.0 | GO:0048485 | sympathetic nervous system development(GO:0048485) |
0.0 | 0.3 | GO:0009062 | fatty acid catabolic process(GO:0009062) |
0.0 | 0.1 | GO:0060134 | prepulse inhibition(GO:0060134) |
0.0 | 0.1 | GO:0006907 | pinocytosis(GO:0006907) |
0.0 | 0.2 | GO:0043526 | obsolete neuroprotection(GO:0043526) |
0.0 | 0.1 | GO:0050732 | negative regulation of peptidyl-tyrosine phosphorylation(GO:0050732) |
0.0 | 0.0 | GO:0032147 | activation of protein kinase activity(GO:0032147) |
0.0 | 0.1 | GO:0031033 | myosin filament organization(GO:0031033) |
0.0 | 0.6 | GO:0006302 | double-strand break repair(GO:0006302) |
0.0 | 0.1 | GO:0046653 | tetrahydrofolate metabolic process(GO:0046653) |
0.0 | 0.0 | GO:0031558 | obsolete induction of apoptosis in response to chemical stimulus(GO:0031558) |
0.0 | 0.2 | GO:0009312 | oligosaccharide biosynthetic process(GO:0009312) |
0.0 | 0.1 | GO:0005997 | xylulose metabolic process(GO:0005997) |
0.0 | 0.1 | GO:0060484 | lung-associated mesenchyme development(GO:0060484) |
0.0 | 0.0 | GO:0034067 | protein localization to Golgi apparatus(GO:0034067) |
0.0 | 0.2 | GO:0070588 | calcium ion transmembrane transport(GO:0070588) |
0.0 | 3.1 | GO:0043632 | modification-dependent macromolecule catabolic process(GO:0043632) |
0.0 | 0.1 | GO:0051918 | negative regulation of fibrinolysis(GO:0051918) |
0.0 | 0.6 | GO:0050772 | positive regulation of axonogenesis(GO:0050772) |
0.0 | 0.1 | GO:0042339 | keratan sulfate metabolic process(GO:0042339) |
0.0 | 0.3 | GO:0019184 | glutathione biosynthetic process(GO:0006750) nonribosomal peptide biosynthetic process(GO:0019184) |
0.0 | 3.6 | GO:0006457 | protein folding(GO:0006457) |
0.0 | 0.1 | GO:0060155 | platelet dense granule organization(GO:0060155) |
0.0 | 0.1 | GO:0000077 | DNA damage checkpoint(GO:0000077) |
0.0 | 0.3 | GO:0048477 | oogenesis(GO:0048477) |
0.0 | 0.0 | GO:0032025 | response to cobalt ion(GO:0032025) |
0.0 | 0.1 | GO:0071285 | cellular response to lithium ion(GO:0071285) |
0.0 | 0.1 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
0.0 | 0.0 | GO:0002068 | glandular epithelial cell development(GO:0002068) |
0.0 | 0.2 | GO:0000270 | peptidoglycan metabolic process(GO:0000270) peptidoglycan catabolic process(GO:0009253) |
0.0 | 0.3 | GO:0006289 | nucleotide-excision repair(GO:0006289) |
0.0 | 0.1 | GO:0045048 | protein insertion into ER membrane(GO:0045048) tail-anchored membrane protein insertion into ER membrane(GO:0071816) |
0.0 | 0.0 | GO:0051290 | protein heterotetramerization(GO:0051290) |
0.0 | 0.3 | GO:0015721 | bile acid and bile salt transport(GO:0015721) |
0.0 | 0.9 | GO:0007162 | negative regulation of cell adhesion(GO:0007162) |
0.0 | 0.1 | GO:0043243 | positive regulation of protein complex disassembly(GO:0043243) positive regulation of protein depolymerization(GO:1901881) |
0.0 | 0.2 | GO:0043101 | purine-containing compound salvage(GO:0043101) |
0.0 | 0.1 | GO:0046479 | glycosphingolipid catabolic process(GO:0046479) |
0.0 | 0.2 | GO:0007210 | serotonin receptor signaling pathway(GO:0007210) |
0.0 | 0.5 | GO:0006730 | one-carbon metabolic process(GO:0006730) |
0.0 | 1.1 | GO:0071357 | type I interferon signaling pathway(GO:0060337) cellular response to type I interferon(GO:0071357) |
0.0 | 0.2 | GO:0019835 | cytolysis(GO:0019835) |
0.0 | 4.0 | GO:0051056 | regulation of small GTPase mediated signal transduction(GO:0051056) |
0.0 | 0.0 | GO:2000179 | positive regulation of neural precursor cell proliferation(GO:2000179) |
0.0 | 0.1 | GO:0015851 | nucleobase transport(GO:0015851) |
0.0 | 0.0 | GO:0030101 | natural killer cell activation(GO:0030101) |
0.0 | 2.4 | GO:0006470 | protein dephosphorylation(GO:0006470) |
0.0 | 0.3 | GO:0017187 | peptidyl-glutamic acid carboxylation(GO:0017187) protein carboxylation(GO:0018214) |
0.0 | 0.1 | GO:0071318 | cellular response to ATP(GO:0071318) |
0.0 | 5.1 | GO:0044419 | interspecies interaction between organisms(GO:0044419) |
0.0 | 0.0 | GO:0014821 | phasic smooth muscle contraction(GO:0014821) |
0.0 | 0.0 | GO:0030325 | adrenal gland development(GO:0030325) |
0.0 | 0.1 | GO:0045116 | protein neddylation(GO:0045116) |
0.0 | 0.0 | GO:2000171 | negative regulation of dendrite development(GO:2000171) |
0.0 | 0.7 | GO:0008277 | regulation of G-protein coupled receptor protein signaling pathway(GO:0008277) |
0.0 | 0.2 | GO:0032092 | positive regulation of protein binding(GO:0032092) |
0.0 | 0.0 | GO:0008628 | hormone-mediated apoptotic signaling pathway(GO:0008628) |
0.0 | 0.1 | GO:0051205 | protein insertion into membrane(GO:0051205) |
0.0 | 0.1 | GO:0046339 | diacylglycerol metabolic process(GO:0046339) |
0.0 | 0.1 | GO:0045667 | regulation of osteoblast differentiation(GO:0045667) |
0.0 | 0.1 | GO:0006498 | N-terminal protein lipidation(GO:0006498) |
0.0 | 0.1 | GO:0050764 | regulation of phagocytosis(GO:0050764) |
0.0 | 0.6 | GO:0015682 | ferric iron transport(GO:0015682) transferrin transport(GO:0033572) trivalent inorganic cation transport(GO:0072512) |
0.0 | 0.0 | GO:0014037 | Schwann cell differentiation(GO:0014037) |
0.0 | 0.1 | GO:0030206 | chondroitin sulfate biosynthetic process(GO:0030206) |
0.0 | 2.3 | GO:0050776 | regulation of immune response(GO:0050776) |
0.0 | 0.1 | GO:0051318 | G1 phase(GO:0051318) |
0.0 | 0.1 | GO:0032411 | positive regulation of transporter activity(GO:0032411) |
0.0 | 0.1 | GO:0061302 | smooth muscle cell-matrix adhesion(GO:0061302) |
0.0 | 0.1 | GO:0032769 | negative regulation of monooxygenase activity(GO:0032769) |
0.0 | 0.1 | GO:0006688 | glycosphingolipid biosynthetic process(GO:0006688) |
0.0 | 0.0 | GO:0072176 | nephric duct development(GO:0072176) |
0.0 | 0.5 | GO:0007286 | spermatid development(GO:0007286) |
0.0 | 0.2 | GO:0033209 | tumor necrosis factor-mediated signaling pathway(GO:0033209) |
0.0 | 0.1 | GO:0007500 | mesodermal cell fate determination(GO:0007500) |
0.0 | 0.0 | GO:1900078 | positive regulation of insulin receptor signaling pathway(GO:0046628) positive regulation of cellular response to insulin stimulus(GO:1900078) |
0.0 | 0.1 | GO:0010259 | multicellular organism aging(GO:0010259) |
0.0 | 0.1 | GO:0050999 | regulation of nitric-oxide synthase activity(GO:0050999) |
0.0 | 0.3 | GO:0007379 | segment specification(GO:0007379) |
0.0 | 0.1 | GO:0030146 | obsolete diuresis(GO:0030146) |
0.0 | 0.1 | GO:0015804 | neutral amino acid transport(GO:0015804) |
0.0 | 0.1 | GO:0006552 | leucine catabolic process(GO:0006552) |
0.0 | 0.0 | GO:0002076 | osteoblast development(GO:0002076) |
0.0 | 0.0 | GO:0042249 | establishment of planar polarity of embryonic epithelium(GO:0042249) |
0.0 | 0.3 | GO:0000910 | cytokinesis(GO:0000910) |
0.0 | 0.1 | GO:0032094 | response to food(GO:0032094) |
0.0 | 0.0 | GO:0030252 | growth hormone secretion(GO:0030252) |
0.0 | 0.0 | GO:0071356 | cellular response to tumor necrosis factor(GO:0071356) |
0.0 | 1.5 | GO:0016567 | protein ubiquitination(GO:0016567) |
0.0 | 0.3 | GO:0006304 | DNA modification(GO:0006304) |
0.0 | 0.1 | GO:0046685 | response to arsenic-containing substance(GO:0046685) |
0.0 | 0.1 | GO:0048169 | regulation of long-term neuronal synaptic plasticity(GO:0048169) |
0.0 | 0.0 | GO:0048665 | neuron fate specification(GO:0048665) |
0.0 | 0.1 | GO:0043537 | negative regulation of blood vessel endothelial cell migration(GO:0043537) |
0.0 | 0.0 | GO:0032148 | activation of protein kinase B activity(GO:0032148) |
0.0 | 0.0 | GO:0019884 | antigen processing and presentation of exogenous antigen(GO:0019884) |
0.0 | 0.0 | GO:0071445 | obsolete cellular response to protein stimulus(GO:0071445) |
0.0 | 0.0 | GO:0072332 | intrinsic apoptotic signaling pathway by p53 class mediator(GO:0072332) |
0.0 | 0.1 | GO:0030279 | negative regulation of ossification(GO:0030279) |
0.0 | 0.0 | GO:0006590 | thyroid hormone generation(GO:0006590) |
0.0 | 0.1 | GO:0048935 | peripheral nervous system neuron development(GO:0048935) |
0.0 | 0.0 | GO:0006264 | mitochondrial DNA replication(GO:0006264) |
0.0 | 0.0 | GO:0021542 | dentate gyrus development(GO:0021542) |
0.0 | 0.1 | GO:0006704 | glucocorticoid biosynthetic process(GO:0006704) |
0.0 | 0.1 | GO:0006284 | base-excision repair(GO:0006284) |
0.0 | 0.2 | GO:0008655 | pyrimidine-containing compound salvage(GO:0008655) pyrimidine nucleoside salvage(GO:0043097) |
0.0 | 0.5 | GO:0015718 | monocarboxylic acid transport(GO:0015718) |
0.0 | 0.1 | GO:0007140 | male meiosis(GO:0007140) |
0.0 | 0.0 | GO:0007031 | peroxisome organization(GO:0007031) |
0.0 | 0.0 | GO:0031268 | pseudopodium organization(GO:0031268) |
0.0 | 0.1 | GO:0045039 | protein import into mitochondrial inner membrane(GO:0045039) |
0.0 | 0.0 | GO:0048755 | branching morphogenesis of a nerve(GO:0048755) |
0.0 | 0.0 | GO:0009125 | nucleoside monophosphate catabolic process(GO:0009125) |
0.0 | 0.2 | GO:0043574 | protein targeting to peroxisome(GO:0006625) peroxisomal transport(GO:0043574) protein localization to peroxisome(GO:0072662) establishment of protein localization to peroxisome(GO:0072663) |
0.0 | 0.0 | GO:0048017 | phosphatidylinositol-mediated signaling(GO:0048015) inositol lipid-mediated signaling(GO:0048017) |
0.0 | 0.2 | GO:0045333 | cellular respiration(GO:0045333) |
0.0 | 0.2 | GO:0042743 | hydrogen peroxide metabolic process(GO:0042743) |
0.0 | 0.1 | GO:0042113 | B cell activation(GO:0042113) |
0.0 | 0.2 | GO:0034440 | fatty acid oxidation(GO:0019395) lipid oxidation(GO:0034440) |
0.0 | 0.2 | GO:0035115 | embryonic forelimb morphogenesis(GO:0035115) |
0.0 | 0.0 | GO:0030851 | granulocyte differentiation(GO:0030851) |
0.0 | 0.1 | GO:0006890 | retrograde vesicle-mediated transport, Golgi to ER(GO:0006890) |
0.0 | 0.0 | GO:0003310 | pancreatic A cell differentiation(GO:0003310) |
0.0 | 0.0 | GO:0040037 | negative regulation of fibroblast growth factor receptor signaling pathway(GO:0040037) |
0.0 | 0.1 | GO:0045669 | positive regulation of osteoblast differentiation(GO:0045669) |
0.0 | 0.0 | GO:0002504 | antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002504) |
0.0 | 0.0 | GO:0050951 | sensory perception of temperature stimulus(GO:0050951) |
0.0 | 0.1 | GO:0072666 | protein targeting to lysosome(GO:0006622) protein targeting to vacuole(GO:0006623) protein localization to lysosome(GO:0061462) protein localization to vacuole(GO:0072665) establishment of protein localization to vacuole(GO:0072666) |
0.0 | 0.0 | GO:1902803 | regulation of synaptic vesicle transport(GO:1902803) regulation of synaptic vesicle exocytosis(GO:2000300) |
0.0 | 0.0 | GO:0032367 | intracellular sterol transport(GO:0032366) intracellular cholesterol transport(GO:0032367) |
0.0 | 0.1 | GO:0006020 | inositol metabolic process(GO:0006020) |
0.0 | 0.0 | GO:0032048 | phosphatidylglycerol biosynthetic process(GO:0006655) cardiolipin metabolic process(GO:0032048) cardiolipin biosynthetic process(GO:0032049) phosphatidylglycerol metabolic process(GO:0046471) |
0.0 | 1.5 | GO:0007067 | mitotic nuclear division(GO:0007067) |
0.0 | 0.1 | GO:0051145 | smooth muscle cell differentiation(GO:0051145) |
0.0 | 0.0 | GO:0045932 | negative regulation of muscle contraction(GO:0045932) |
0.0 | 0.0 | GO:0009650 | UV protection(GO:0009650) |
0.0 | 0.1 | GO:0007040 | lysosome organization(GO:0007040) lytic vacuole organization(GO:0080171) |
0.0 | 0.1 | GO:0048857 | neural nucleus development(GO:0048857) |
0.0 | 0.1 | GO:0070189 | kynurenine metabolic process(GO:0070189) |
0.0 | 0.7 | GO:0008203 | cholesterol metabolic process(GO:0008203) |
0.0 | 0.4 | GO:0007498 | mesoderm development(GO:0007498) |
0.0 | 0.2 | GO:0050885 | neuromuscular process controlling balance(GO:0050885) |
0.0 | 0.1 | GO:0007350 | blastoderm segmentation(GO:0007350) |
0.0 | 0.0 | GO:0060443 | mammary gland morphogenesis(GO:0060443) |
0.0 | 0.1 | GO:0001906 | cell killing(GO:0001906) |
0.0 | 0.1 | GO:0016098 | monoterpenoid metabolic process(GO:0016098) |
0.0 | 0.0 | GO:0060122 | inner ear receptor stereocilium organization(GO:0060122) |
0.0 | 0.0 | GO:0007616 | long-term memory(GO:0007616) |
0.0 | 0.1 | GO:0006662 | glycerol ether metabolic process(GO:0006662) ether metabolic process(GO:0018904) |
0.0 | 0.0 | GO:0050435 | beta-amyloid metabolic process(GO:0050435) |
0.0 | 0.0 | GO:0043030 | regulation of macrophage activation(GO:0043030) |
0.0 | 0.3 | GO:0043406 | positive regulation of MAP kinase activity(GO:0043406) |
0.0 | 0.0 | GO:0006012 | galactose metabolic process(GO:0006012) |
0.0 | 0.1 | GO:0018101 | protein citrullination(GO:0018101) citrulline biosynthetic process(GO:0019240) |
0.0 | 0.1 | GO:0030309 | poly-N-acetyllactosamine metabolic process(GO:0030309) |
0.0 | 0.0 | GO:0035082 | axoneme assembly(GO:0035082) |
0.0 | 0.1 | GO:0007051 | spindle organization(GO:0007051) |
0.0 | 0.0 | GO:0035590 | purinergic nucleotide receptor signaling pathway(GO:0035590) |
0.0 | 0.0 | GO:0042487 | regulation of odontogenesis of dentin-containing tooth(GO:0042487) |
0.0 | 0.1 | GO:0007216 | G-protein coupled glutamate receptor signaling pathway(GO:0007216) |
0.0 | 0.1 | GO:0050805 | negative regulation of synaptic transmission(GO:0050805) |
0.0 | 0.8 | GO:0045087 | innate immune response(GO:0045087) |
0.0 | 0.1 | GO:0051481 | negative regulation of cytosolic calcium ion concentration(GO:0051481) |
0.0 | 0.0 | GO:0014888 | striated muscle adaptation(GO:0014888) |
0.0 | 0.0 | GO:0035235 | ionotropic glutamate receptor signaling pathway(GO:0035235) |
0.0 | 0.1 | GO:0070328 | acylglycerol homeostasis(GO:0055090) triglyceride homeostasis(GO:0070328) |
0.0 | 0.0 | GO:0046328 | regulation of JNK cascade(GO:0046328) |
0.0 | 0.3 | GO:0019722 | calcium-mediated signaling(GO:0019722) |
0.0 | 0.0 | GO:0021930 | cell proliferation in hindbrain(GO:0021534) cell proliferation in external granule layer(GO:0021924) cerebellar granule cell precursor proliferation(GO:0021930) |
0.0 | 0.0 | GO:0045110 | intermediate filament bundle assembly(GO:0045110) |
0.0 | 1.0 | GO:0046034 | ATP metabolic process(GO:0046034) |
0.0 | 0.0 | GO:0009948 | anterior/posterior axis specification(GO:0009948) |
0.0 | 0.2 | GO:0006004 | fucose metabolic process(GO:0006004) |
0.0 | 0.0 | GO:0002090 | regulation of receptor internalization(GO:0002090) |
0.0 | 0.1 | GO:0007215 | glutamate receptor signaling pathway(GO:0007215) |
0.0 | 0.0 | GO:0051101 | regulation of DNA binding(GO:0051101) |
0.0 | 0.0 | GO:0042756 | drinking behavior(GO:0042756) |
0.0 | 0.1 | GO:0050832 | defense response to fungus(GO:0050832) |
0.0 | 0.0 | GO:0006549 | isoleucine metabolic process(GO:0006549) |
0.0 | 0.1 | GO:0033189 | response to vitamin A(GO:0033189) |
0.0 | 0.0 | GO:0060711 | labyrinthine layer development(GO:0060711) |
0.0 | 0.0 | GO:0001706 | endoderm formation(GO:0001706) |
0.0 | 17.0 | GO:0032774 | RNA biosynthetic process(GO:0032774) |
0.0 | 0.1 | GO:0001947 | heart looping(GO:0001947) embryonic heart tube morphogenesis(GO:0003143) determination of heart left/right asymmetry(GO:0061371) |
0.0 | 1.7 | GO:0006955 | immune response(GO:0006955) |
0.0 | 0.1 | GO:0022616 | DNA strand elongation(GO:0022616) |
0.0 | 0.5 | GO:0006979 | response to oxidative stress(GO:0006979) |
0.0 | 0.0 | GO:0019236 | response to pheromone(GO:0019236) |
0.0 | 0.1 | GO:0051350 | negative regulation of adenylate cyclase activity(GO:0007194) negative regulation of cyclase activity(GO:0031280) negative regulation of lyase activity(GO:0051350) |
0.0 | 0.2 | GO:0030163 | protein catabolic process(GO:0030163) |
0.0 | 0.1 | GO:0006577 | amino-acid betaine metabolic process(GO:0006577) carnitine metabolic process(GO:0009437) |
0.0 | 0.0 | GO:0009134 | nucleoside diphosphate catabolic process(GO:0009134) ribonucleoside diphosphate catabolic process(GO:0009191) |
0.0 | 0.1 | GO:0009309 | amine biosynthetic process(GO:0009309) |
0.0 | 0.0 | GO:0046874 | quinolinate metabolic process(GO:0046874) |
0.0 | 0.0 | GO:0018200 | peptidyl-glutamic acid modification(GO:0018200) |
0.0 | 0.0 | GO:0051187 | cofactor catabolic process(GO:0051187) |
0.0 | 0.0 | GO:0048484 | enteric nervous system development(GO:0048484) |
0.0 | 0.0 | GO:0001881 | receptor recycling(GO:0001881) |
0.0 | 0.1 | GO:0006544 | glycine metabolic process(GO:0006544) |
0.0 | 0.0 | GO:0019852 | L-ascorbic acid metabolic process(GO:0019852) |
0.0 | 0.0 | GO:0032570 | response to progesterone(GO:0032570) |
0.0 | 0.0 | GO:0043094 | cellular metabolic compound salvage(GO:0043094) |
0.0 | 0.3 | GO:0016197 | endosomal transport(GO:0016197) |
0.0 | 1.9 | GO:0050817 | coagulation(GO:0050817) |
0.0 | 0.3 | GO:0009615 | response to virus(GO:0009615) |
0.0 | 0.0 | GO:0043954 | cell junction maintenance(GO:0034331) cellular component maintenance(GO:0043954) cell-cell junction maintenance(GO:0045217) |
0.0 | 0.0 | GO:0048265 | response to pain(GO:0048265) |
0.0 | 0.2 | GO:0016339 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
0.0 | 0.0 | GO:0051771 | negative regulation of nitric-oxide synthase biosynthetic process(GO:0051771) |
0.0 | 0.0 | GO:0015670 | carbon dioxide transport(GO:0015670) |
0.0 | 0.0 | GO:0060079 | excitatory postsynaptic potential(GO:0060079) |
0.0 | 0.0 | GO:0002042 | cell migration involved in sprouting angiogenesis(GO:0002042) |
0.0 | 0.0 | GO:0030225 | macrophage differentiation(GO:0030225) |
0.0 | 0.7 | GO:0007018 | microtubule-based movement(GO:0007018) |
0.0 | 0.0 | GO:0001522 | pseudouridine synthesis(GO:0001522) |
0.0 | 0.0 | GO:0042036 | negative regulation of cytokine biosynthetic process(GO:0042036) |
0.0 | 0.1 | GO:0051168 | nuclear export(GO:0051168) |
0.0 | 0.2 | GO:0097194 | cellular component disassembly involved in execution phase of apoptosis(GO:0006921) execution phase of apoptosis(GO:0097194) |
0.0 | 0.2 | GO:0007265 | Ras protein signal transduction(GO:0007265) |
0.0 | 0.2 | GO:0018298 | protein-chromophore linkage(GO:0018298) |
0.0 | 0.0 | GO:0071241 | cellular response to inorganic substance(GO:0071241) |
0.0 | 0.1 | GO:0099504 | synaptic vesicle cycle(GO:0099504) |
0.0 | 0.6 | GO:0006836 | neurotransmitter transport(GO:0006836) |
0.0 | 0.0 | GO:0051974 | negative regulation of telomerase activity(GO:0051974) |
0.0 | 2.5 | GO:0012501 | programmed cell death(GO:0012501) |
0.0 | 0.1 | GO:0006892 | post-Golgi vesicle-mediated transport(GO:0006892) |
0.0 | 0.0 | GO:0034214 | protein hexamerization(GO:0034214) |
0.0 | 0.0 | GO:0043569 | negative regulation of insulin-like growth factor receptor signaling pathway(GO:0043569) |
0.0 | 0.0 | GO:0018208 | peptidyl-proline modification(GO:0018208) |
0.0 | 0.9 | GO:0007264 | small GTPase mediated signal transduction(GO:0007264) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.4 | 1.1 | GO:0042105 | alpha-beta T cell receptor complex(GO:0042105) |
0.3 | 1.0 | GO:0072487 | MSL complex(GO:0072487) |
0.3 | 1.0 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
0.3 | 0.9 | GO:0070022 | transforming growth factor beta receptor homodimeric complex(GO:0070022) |
0.3 | 0.9 | GO:0000306 | extrinsic component of vacuolar membrane(GO:0000306) extrinsic component of endosome membrane(GO:0031313) |
0.3 | 0.9 | GO:0032444 | activin responsive factor complex(GO:0032444) |
0.3 | 0.9 | GO:0000942 | condensed nuclear chromosome outer kinetochore(GO:0000942) |
0.3 | 1.4 | GO:0005797 | Golgi medial cisterna(GO:0005797) |
0.3 | 1.7 | GO:0071778 | obsolete WINAC complex(GO:0071778) |
0.3 | 0.5 | GO:0031300 | intrinsic component of organelle membrane(GO:0031300) |
0.3 | 1.9 | GO:0001891 | phagocytic cup(GO:0001891) |
0.3 | 0.8 | GO:0071942 | XPC complex(GO:0071942) |
0.2 | 3.4 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
0.2 | 0.5 | GO:0019867 | outer membrane(GO:0019867) |
0.2 | 1.8 | GO:0019773 | proteasome core complex, alpha-subunit complex(GO:0019773) |
0.2 | 1.4 | GO:0005658 | alpha DNA polymerase:primase complex(GO:0005658) |
0.2 | 1.6 | GO:0034451 | centriolar satellite(GO:0034451) |
0.2 | 0.4 | GO:0031932 | TORC2 complex(GO:0031932) |
0.2 | 2.5 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
0.2 | 0.2 | GO:0001740 | Barr body(GO:0001740) |
0.2 | 0.8 | GO:0031229 | integral component of nuclear inner membrane(GO:0005639) intrinsic component of nuclear inner membrane(GO:0031229) nuclear membrane part(GO:0044453) |
0.2 | 1.8 | GO:0042101 | T cell receptor complex(GO:0042101) |
0.2 | 1.2 | GO:0031616 | spindle pole centrosome(GO:0031616) |
0.2 | 1.9 | GO:0008180 | COP9 signalosome(GO:0008180) |
0.2 | 1.9 | GO:0031080 | nuclear pore outer ring(GO:0031080) |
0.2 | 3.2 | GO:0030530 | obsolete heterogeneous nuclear ribonucleoprotein complex(GO:0030530) |
0.2 | 0.8 | GO:0005667 | transcription factor complex(GO:0005667) |
0.2 | 3.7 | GO:0031519 | PcG protein complex(GO:0031519) |
0.2 | 0.7 | GO:0034045 | pre-autophagosomal structure membrane(GO:0034045) |
0.2 | 0.6 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.2 | 0.6 | GO:0014731 | spectrin-associated cytoskeleton(GO:0014731) |
0.2 | 3.5 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.2 | 0.5 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.2 | 0.9 | GO:0000109 | nucleotide-excision repair complex(GO:0000109) |
0.2 | 0.7 | GO:0033553 | rDNA heterochromatin(GO:0033553) |
0.2 | 0.7 | GO:0016589 | NURF complex(GO:0016589) |
0.2 | 0.7 | GO:0005736 | DNA-directed RNA polymerase I complex(GO:0005736) |
0.2 | 1.0 | GO:0000796 | condensin complex(GO:0000796) |
0.2 | 1.0 | GO:0031264 | death-inducing signaling complex(GO:0031264) |
0.2 | 0.9 | GO:0070776 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
0.2 | 0.2 | GO:0012505 | endomembrane system(GO:0012505) |
0.2 | 0.7 | GO:0005827 | polar microtubule(GO:0005827) |
0.2 | 0.5 | GO:0005826 | actomyosin contractile ring(GO:0005826) |
0.2 | 0.3 | GO:0009898 | cytoplasmic side of plasma membrane(GO:0009898) |
0.2 | 1.4 | GO:0034518 | mRNA cap binding complex(GO:0005845) RNA cap binding complex(GO:0034518) |
0.2 | 0.8 | GO:0044224 | juxtaparanode region of axon(GO:0044224) |
0.2 | 0.6 | GO:0031465 | Cul4B-RING E3 ubiquitin ligase complex(GO:0031465) |
0.2 | 1.7 | GO:0001772 | immunological synapse(GO:0001772) |
0.1 | 0.9 | GO:0070822 | Sin3 complex(GO:0016580) Sin3-type complex(GO:0070822) |
0.1 | 0.6 | GO:0016593 | Cdc73/Paf1 complex(GO:0016593) |
0.1 | 2.2 | GO:0080008 | Cul4-RING E3 ubiquitin ligase complex(GO:0080008) |
0.1 | 1.3 | GO:0016585 | obsolete chromatin remodeling complex(GO:0016585) |
0.1 | 0.7 | GO:0000791 | euchromatin(GO:0000791) |
0.1 | 0.7 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
0.1 | 2.1 | GO:0043209 | myelin sheath(GO:0043209) |
0.1 | 0.7 | GO:0031254 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
0.1 | 1.2 | GO:0042598 | obsolete vesicular fraction(GO:0042598) |
0.1 | 1.4 | GO:0016514 | SWI/SNF complex(GO:0016514) |
0.1 | 1.0 | GO:0070688 | MLL5-L complex(GO:0070688) |
0.1 | 1.3 | GO:0005838 | proteasome regulatory particle(GO:0005838) |
0.1 | 0.8 | GO:0005883 | neurofilament(GO:0005883) |
0.1 | 1.4 | GO:0090533 | cation-transporting ATPase complex(GO:0090533) |
0.1 | 1.4 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
0.1 | 1.0 | GO:0005849 | mRNA cleavage factor complex(GO:0005849) |
0.1 | 0.1 | GO:0016461 | unconventional myosin complex(GO:0016461) |
0.1 | 0.5 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) |
0.1 | 0.4 | GO:0005787 | signal peptidase complex(GO:0005787) |
0.1 | 0.5 | GO:0005672 | transcription factor TFIIA complex(GO:0005672) |
0.1 | 0.8 | GO:0000940 | condensed chromosome outer kinetochore(GO:0000940) |
0.1 | 1.7 | GO:0030914 | STAGA complex(GO:0030914) |
0.1 | 0.4 | GO:0070545 | PeBoW complex(GO:0070545) |
0.1 | 0.8 | GO:0030027 | lamellipodium(GO:0030027) |
0.1 | 1.0 | GO:0045120 | pronucleus(GO:0045120) |
0.1 | 0.4 | GO:0042584 | chromaffin granule(GO:0042583) chromaffin granule membrane(GO:0042584) |
0.1 | 0.1 | GO:0044309 | neuron spine(GO:0044309) |
0.1 | 0.4 | GO:0032279 | asymmetric synapse(GO:0032279) neuron to neuron synapse(GO:0098984) |
0.1 | 2.0 | GO:0005669 | transcription factor TFIID complex(GO:0005669) |
0.1 | 1.2 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
0.1 | 0.7 | GO:0042382 | paraspeckles(GO:0042382) |
0.1 | 0.7 | GO:0030134 | ER to Golgi transport vesicle(GO:0030134) |
0.1 | 0.7 | GO:0030992 | intraciliary transport particle B(GO:0030992) |
0.1 | 0.5 | GO:0031428 | box C/D snoRNP complex(GO:0031428) |
0.1 | 0.8 | GO:0090576 | RNA polymerase III transcription factor complex(GO:0090576) |
0.1 | 1.5 | GO:0005852 | eukaryotic translation initiation factor 3 complex(GO:0005852) |
0.1 | 0.5 | GO:0005850 | eukaryotic translation initiation factor 2 complex(GO:0005850) |
0.1 | 0.5 | GO:0043296 | apical junction complex(GO:0043296) |
0.1 | 4.4 | GO:0030964 | mitochondrial respiratory chain complex I(GO:0005747) NADH dehydrogenase complex(GO:0030964) respiratory chain complex I(GO:0045271) |
0.1 | 0.1 | GO:0005694 | chromosome(GO:0005694) |
0.1 | 0.2 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
0.1 | 0.7 | GO:0000276 | mitochondrial proton-transporting ATP synthase complex, coupling factor F(o)(GO:0000276) |
0.1 | 1.2 | GO:0035631 | CD40 receptor complex(GO:0035631) |
0.1 | 0.2 | GO:0000242 | pericentriolar material(GO:0000242) |
0.1 | 0.2 | GO:0030897 | HOPS complex(GO:0030897) |
0.1 | 0.6 | GO:0000275 | mitochondrial proton-transporting ATP synthase complex, catalytic core F(1)(GO:0000275) |
0.1 | 0.3 | GO:0034361 | very-low-density lipoprotein particle(GO:0034361) triglyceride-rich lipoprotein particle(GO:0034385) |
0.1 | 2.2 | GO:0000932 | cytoplasmic mRNA processing body(GO:0000932) |
0.1 | 0.6 | GO:0000145 | exocyst(GO:0000145) |
0.1 | 1.3 | GO:0034362 | low-density lipoprotein particle(GO:0034362) |
0.1 | 0.3 | GO:0071986 | Ragulator complex(GO:0071986) |
0.1 | 0.6 | GO:0032590 | dendrite membrane(GO:0032590) |
0.1 | 0.7 | GO:0000346 | transcription export complex(GO:0000346) |
0.1 | 1.8 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
0.1 | 0.8 | GO:0000808 | origin recognition complex(GO:0000808) nuclear origin of replication recognition complex(GO:0005664) |
0.1 | 0.1 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
0.1 | 0.2 | GO:0031205 | endoplasmic reticulum Sec complex(GO:0031205) |
0.1 | 0.6 | GO:0032040 | small-subunit processome(GO:0032040) |
0.1 | 4.4 | GO:0030173 | integral component of Golgi membrane(GO:0030173) |
0.1 | 11.3 | GO:0016607 | nuclear speck(GO:0016607) |
0.1 | 1.0 | GO:0005671 | Ada2/Gcn5/Ada3 transcription activator complex(GO:0005671) |
0.1 | 2.1 | GO:0005637 | nuclear inner membrane(GO:0005637) |
0.1 | 0.2 | GO:0005954 | calcium- and calmodulin-dependent protein kinase complex(GO:0005954) |
0.1 | 1.0 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
0.1 | 0.2 | GO:0031010 | ISWI-type complex(GO:0031010) |
0.1 | 0.3 | GO:0030895 | apolipoprotein B mRNA editing enzyme complex(GO:0030895) |
0.1 | 0.4 | GO:0031371 | ubiquitin conjugating enzyme complex(GO:0031371) |
0.1 | 0.3 | GO:0005594 | collagen type IX trimer(GO:0005594) |
0.1 | 0.2 | GO:0044462 | external encapsulating structure part(GO:0044462) |
0.1 | 0.9 | GO:0017119 | Golgi transport complex(GO:0017119) |
0.1 | 0.4 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
0.1 | 0.2 | GO:0038201 | TORC1 complex(GO:0031931) TOR complex(GO:0038201) |
0.1 | 0.4 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
0.1 | 1.9 | GO:0005689 | U12-type spliceosomal complex(GO:0005689) |
0.1 | 0.7 | GO:0042555 | MCM complex(GO:0042555) |
0.1 | 0.6 | GO:0030532 | small nuclear ribonucleoprotein complex(GO:0030532) |
0.1 | 0.6 | GO:0043190 | ATP-binding cassette (ABC) transporter complex(GO:0043190) |
0.1 | 0.7 | GO:0048786 | presynaptic active zone(GO:0048786) |
0.1 | 0.2 | GO:0016528 | sarcoplasm(GO:0016528) |
0.1 | 0.3 | GO:0005784 | Sec61 translocon complex(GO:0005784) translocon complex(GO:0071256) |
0.1 | 0.2 | GO:0071817 | MMXD complex(GO:0071817) |
0.1 | 0.5 | GO:0005869 | dynactin complex(GO:0005869) |
0.1 | 4.6 | GO:0031901 | early endosome membrane(GO:0031901) |
0.1 | 1.8 | GO:0008287 | protein serine/threonine phosphatase complex(GO:0008287) phosphatase complex(GO:1903293) |
0.1 | 0.5 | GO:0042827 | platelet dense granule(GO:0042827) |
0.1 | 1.7 | GO:0034708 | methyltransferase complex(GO:0034708) histone methyltransferase complex(GO:0035097) |
0.1 | 0.5 | GO:0005663 | DNA replication factor C complex(GO:0005663) |
0.1 | 3.8 | GO:0000502 | proteasome complex(GO:0000502) |
0.1 | 0.2 | GO:0005638 | lamin filament(GO:0005638) |
0.1 | 2.6 | GO:0030175 | filopodium(GO:0030175) |
0.1 | 1.5 | GO:0005763 | organellar small ribosomal subunit(GO:0000314) mitochondrial small ribosomal subunit(GO:0005763) |
0.1 | 0.2 | GO:0031904 | endosome lumen(GO:0031904) |
0.1 | 0.6 | GO:0070531 | BRCA1-A complex(GO:0070531) |
0.1 | 0.2 | GO:0031332 | RISC complex(GO:0016442) RNAi effector complex(GO:0031332) |
0.1 | 2.2 | GO:0005876 | spindle microtubule(GO:0005876) |
0.1 | 0.3 | GO:0031094 | platelet dense tubular network(GO:0031094) |
0.1 | 0.2 | GO:0005796 | Golgi lumen(GO:0005796) |
0.1 | 0.1 | GO:0031304 | intrinsic component of mitochondrial inner membrane(GO:0031304) |
0.1 | 0.2 | GO:0031941 | filamentous actin(GO:0031941) |
0.1 | 3.6 | GO:0000790 | nuclear chromatin(GO:0000790) |
0.1 | 0.2 | GO:0090545 | NuRD complex(GO:0016581) CHD-type complex(GO:0090545) nuclear transcriptional repressor complex(GO:0090568) |
0.1 | 0.2 | GO:0005677 | chromatin silencing complex(GO:0005677) |
0.1 | 0.4 | GO:0032587 | ruffle membrane(GO:0032587) |
0.1 | 1.1 | GO:0032592 | integral component of mitochondrial membrane(GO:0032592) |
0.1 | 0.4 | GO:0005902 | microvillus(GO:0005902) |
0.1 | 0.2 | GO:0001652 | granular component(GO:0001652) |
0.1 | 3.5 | GO:0005769 | early endosome(GO:0005769) |
0.1 | 3.1 | GO:0055037 | recycling endosome(GO:0055037) |
0.1 | 0.5 | GO:0030140 | trans-Golgi network transport vesicle(GO:0030140) |
0.1 | 0.8 | GO:0016471 | vacuolar proton-transporting V-type ATPase complex(GO:0016471) |
0.1 | 0.5 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
0.1 | 0.2 | GO:0015935 | small ribosomal subunit(GO:0015935) |
0.1 | 0.2 | GO:0032009 | early phagosome(GO:0032009) |
0.1 | 0.3 | GO:0045283 | mitochondrial respiratory chain complex II, succinate dehydrogenase complex (ubiquinone)(GO:0005749) succinate dehydrogenase complex (ubiquinone)(GO:0045257) respiratory chain complex II(GO:0045273) succinate dehydrogenase complex(GO:0045281) fumarate reductase complex(GO:0045283) |
0.1 | 0.2 | GO:0070188 | obsolete Stn1-Ten1 complex(GO:0070188) |
0.1 | 0.1 | GO:0035145 | exon-exon junction complex(GO:0035145) |
0.1 | 0.1 | GO:0032449 | CBM complex(GO:0032449) |
0.1 | 2.9 | GO:0016605 | PML body(GO:0016605) |
0.1 | 3.4 | GO:0005793 | endoplasmic reticulum-Golgi intermediate compartment(GO:0005793) |
0.1 | 0.2 | GO:0070820 | tertiary granule(GO:0070820) |
0.1 | 0.1 | GO:0005697 | telomerase holoenzyme complex(GO:0005697) |
0.1 | 0.1 | GO:0070761 | pre-snoRNP complex(GO:0070761) |
0.1 | 0.2 | GO:0005832 | chaperonin-containing T-complex(GO:0005832) |
0.1 | 1.3 | GO:0000781 | chromosome, telomeric region(GO:0000781) |
0.1 | 1.0 | GO:0042613 | MHC class II protein complex(GO:0042613) |
0.1 | 0.1 | GO:0030125 | clathrin vesicle coat(GO:0030125) |
0.1 | 0.1 | GO:0000805 | X chromosome(GO:0000805) |
0.1 | 0.2 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
0.1 | 0.8 | GO:0005744 | mitochondrial inner membrane presequence translocase complex(GO:0005744) |
0.1 | 0.5 | GO:0061200 | clathrin-sculpted gamma-aminobutyric acid transport vesicle(GO:0061200) clathrin-sculpted gamma-aminobutyric acid transport vesicle membrane(GO:0061202) |
0.1 | 0.1 | GO:0000803 | sex chromosome(GO:0000803) |
0.1 | 0.3 | GO:0097425 | smooth endoplasmic reticulum membrane(GO:0030868) smooth endoplasmic reticulum part(GO:0097425) |
0.1 | 0.7 | GO:0032039 | integrator complex(GO:0032039) |
0.1 | 0.3 | GO:0048500 | signal recognition particle, endoplasmic reticulum targeting(GO:0005786) signal recognition particle(GO:0048500) |
0.1 | 0.5 | GO:0043596 | nuclear replication fork(GO:0043596) |
0.1 | 3.2 | GO:0005643 | nuclear pore(GO:0005643) |
0.1 | 0.1 | GO:0045495 | P granule(GO:0043186) pole plasm(GO:0045495) germ plasm(GO:0060293) |
0.1 | 0.3 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
0.1 | 0.2 | GO:0005770 | late endosome(GO:0005770) |
0.1 | 0.2 | GO:0030891 | VCB complex(GO:0030891) |
0.1 | 0.1 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
0.1 | 0.5 | GO:0042575 | DNA polymerase complex(GO:0042575) |
0.1 | 8.1 | GO:0000785 | chromatin(GO:0000785) |
0.1 | 0.9 | GO:0032993 | protein-DNA complex(GO:0032993) |
0.1 | 0.1 | GO:0071564 | npBAF complex(GO:0071564) |
0.1 | 0.5 | GO:0005666 | DNA-directed RNA polymerase III complex(GO:0005666) |
0.1 | 6.1 | GO:0000151 | ubiquitin ligase complex(GO:0000151) |
0.1 | 1.0 | GO:0048475 | membrane coat(GO:0030117) coated membrane(GO:0048475) |
0.1 | 0.1 | GO:0031083 | BLOC complex(GO:0031082) BLOC-1 complex(GO:0031083) |
0.1 | 2.6 | GO:0000777 | condensed chromosome kinetochore(GO:0000777) |
0.1 | 4.2 | GO:0005681 | spliceosomal complex(GO:0005681) |
0.1 | 4.7 | GO:0042470 | melanosome(GO:0042470) pigment granule(GO:0048770) |
0.1 | 0.5 | GO:0000307 | cyclin-dependent protein kinase holoenzyme complex(GO:0000307) |
0.1 | 0.5 | GO:0005626 | obsolete insoluble fraction(GO:0005626) |
0.1 | 0.8 | GO:0005665 | DNA-directed RNA polymerase II, core complex(GO:0005665) |
0.1 | 0.7 | GO:0016363 | nuclear matrix(GO:0016363) |
0.1 | 0.2 | GO:0000407 | pre-autophagosomal structure(GO:0000407) |
0.1 | 0.2 | GO:0005958 | DNA-dependent protein kinase-DNA ligase 4 complex(GO:0005958) |
0.1 | 0.1 | GO:0070552 | BRISC complex(GO:0070552) |
0.1 | 0.3 | GO:0002080 | acrosomal membrane(GO:0002080) |
0.1 | 0.5 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
0.1 | 1.0 | GO:0005746 | mitochondrial respiratory chain(GO:0005746) |
0.1 | 0.4 | GO:0005802 | trans-Golgi network(GO:0005802) |
0.1 | 0.2 | GO:0031228 | intrinsic component of Golgi membrane(GO:0031228) |
0.1 | 0.8 | GO:0005761 | organellar ribosome(GO:0000313) mitochondrial ribosome(GO:0005761) |
0.1 | 0.1 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
0.1 | 0.1 | GO:0031090 | organelle membrane(GO:0031090) |
0.1 | 0.2 | GO:0045179 | apical cortex(GO:0045179) |
0.1 | 0.5 | GO:0032839 | dendrite cytoplasm(GO:0032839) |
0.1 | 0.1 | GO:0031838 | haptoglobin-hemoglobin complex(GO:0031838) |
0.1 | 0.3 | GO:0005790 | smooth endoplasmic reticulum(GO:0005790) |
0.1 | 0.3 | GO:0030121 | AP-1 adaptor complex(GO:0030121) |
0.1 | 0.4 | GO:0043025 | neuronal cell body(GO:0043025) |
0.1 | 0.2 | GO:0000506 | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex(GO:0000506) |
0.1 | 3.4 | GO:0015934 | large ribosomal subunit(GO:0015934) |
0.1 | 0.4 | GO:0005771 | multivesicular body(GO:0005771) |
0.1 | 0.1 | GO:0032133 | chromosome passenger complex(GO:0032133) |
0.1 | 1.9 | GO:0099501 | synaptic vesicle membrane(GO:0030672) exocytic vesicle membrane(GO:0099501) |
0.1 | 0.2 | GO:0045334 | clathrin-coated endocytic vesicle(GO:0045334) |
0.1 | 0.1 | GO:0045261 | proton-transporting ATP synthase complex, catalytic core F(1)(GO:0045261) |
0.1 | 0.1 | GO:0035189 | Rb-E2F complex(GO:0035189) |
0.1 | 0.1 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
0.1 | 1.5 | GO:0042645 | mitochondrial nucleoid(GO:0042645) |
0.1 | 0.2 | GO:0005905 | clathrin-coated pit(GO:0005905) |
0.1 | 0.5 | GO:0032391 | photoreceptor connecting cilium(GO:0032391) |
0.1 | 17.9 | GO:0005654 | nucleoplasm(GO:0005654) |
0.1 | 0.5 | GO:0030663 | COPI-coated vesicle membrane(GO:0030663) |
0.1 | 0.6 | GO:0005844 | polysome(GO:0005844) |
0.1 | 0.2 | GO:0042825 | TAP complex(GO:0042825) |
0.1 | 4.0 | GO:0005788 | endoplasmic reticulum lumen(GO:0005788) |
0.1 | 1.4 | GO:0005758 | mitochondrial intermembrane space(GO:0005758) |
0.1 | 0.4 | GO:0031201 | SNARE complex(GO:0031201) |
0.1 | 0.4 | GO:0005840 | ribosome(GO:0005840) |
0.1 | 0.2 | GO:0071203 | WASH complex(GO:0071203) |
0.1 | 38.8 | GO:0005730 | nucleolus(GO:0005730) |
0.1 | 1.6 | GO:0016592 | mediator complex(GO:0016592) |
0.1 | 2.2 | GO:0044440 | endosomal part(GO:0044440) |
0.1 | 0.2 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
0.1 | 0.4 | GO:0005801 | cis-Golgi network(GO:0005801) |
0.1 | 0.1 | GO:0000800 | lateral element(GO:0000800) |
0.1 | 0.9 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
0.1 | 1.7 | GO:0005777 | peroxisome(GO:0005777) microbody(GO:0042579) |
0.0 | 0.6 | GO:0005779 | integral component of peroxisomal membrane(GO:0005779) intrinsic component of peroxisomal membrane(GO:0031231) |
0.0 | 0.1 | GO:0005577 | fibrinogen complex(GO:0005577) |
0.0 | 0.2 | GO:0000776 | kinetochore(GO:0000776) |
0.0 | 2.9 | GO:0098852 | lysosomal membrane(GO:0005765) lytic vacuole membrane(GO:0098852) |
0.0 | 0.1 | GO:0044304 | main axon(GO:0044304) |
0.0 | 0.2 | GO:0016324 | apical plasma membrane(GO:0016324) |
0.0 | 58.3 | GO:0005829 | cytosol(GO:0005829) |
0.0 | 0.2 | GO:0017059 | palmitoyltransferase complex(GO:0002178) serine C-palmitoyltransferase complex(GO:0017059) endoplasmic reticulum palmitoyltransferase complex(GO:0031211) |
0.0 | 0.6 | GO:0005930 | axoneme(GO:0005930) ciliary plasm(GO:0097014) |
0.0 | 0.2 | GO:0005875 | microtubule associated complex(GO:0005875) |
0.0 | 0.3 | GO:0031258 | lamellipodium membrane(GO:0031258) |
0.0 | 0.2 | GO:0031430 | M band(GO:0031430) |
0.0 | 5.3 | GO:0005874 | microtubule(GO:0005874) |
0.0 | 104.3 | GO:0005634 | nucleus(GO:0005634) |
0.0 | 0.1 | GO:0016323 | basolateral plasma membrane(GO:0016323) |
0.0 | 0.1 | GO:0030660 | Golgi-associated vesicle membrane(GO:0030660) |
0.0 | 0.1 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
0.0 | 0.5 | GO:0005814 | centriole(GO:0005814) |
0.0 | 0.2 | GO:0005913 | cell-cell adherens junction(GO:0005913) |
0.0 | 0.2 | GO:0070652 | HAUS complex(GO:0070652) |
0.0 | 0.2 | GO:0071546 | pi-body(GO:0071546) |
0.0 | 0.2 | GO:0016272 | prefoldin complex(GO:0016272) |
0.0 | 0.1 | GO:0000178 | exosome (RNase complex)(GO:0000178) |
0.0 | 0.3 | GO:0042597 | outer membrane-bounded periplasmic space(GO:0030288) periplasmic space(GO:0042597) |
0.0 | 1.4 | GO:0005813 | centrosome(GO:0005813) |
0.0 | 0.2 | GO:0005742 | mitochondrial outer membrane translocase complex(GO:0005742) |
0.0 | 0.1 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
0.0 | 0.1 | GO:0005776 | autophagosome(GO:0005776) |
0.0 | 1.9 | GO:0045121 | membrane raft(GO:0045121) membrane microdomain(GO:0098857) |
0.0 | 0.1 | GO:0005774 | vacuolar membrane(GO:0005774) |
0.0 | 0.0 | GO:1990204 | oxidoreductase complex(GO:1990204) |
0.0 | 0.1 | GO:0016010 | dystrophin-associated glycoprotein complex(GO:0016010) glycoprotein complex(GO:0090665) |
0.0 | 2.8 | GO:0000323 | lytic vacuole(GO:0000323) lysosome(GO:0005764) |
0.0 | 0.0 | GO:0031253 | cell projection membrane(GO:0031253) |
0.0 | 22.2 | GO:0005739 | mitochondrion(GO:0005739) |
0.0 | 3.2 | GO:0009897 | external side of plasma membrane(GO:0009897) |
0.0 | 12.4 | GO:0042175 | nuclear outer membrane-endoplasmic reticulum membrane network(GO:0042175) |
0.0 | 0.1 | GO:0030529 | intracellular ribonucleoprotein complex(GO:0030529) ribonucleoprotein complex(GO:1990904) |
0.0 | 0.0 | GO:0042599 | lamellar body(GO:0042599) |
0.0 | 0.7 | GO:0005921 | gap junction(GO:0005921) |
0.0 | 0.1 | GO:0033011 | perinuclear theca(GO:0033011) |
0.0 | 0.0 | GO:0001750 | photoreceptor outer segment(GO:0001750) |
0.0 | 0.1 | GO:0000299 | obsolete integral to membrane of membrane fraction(GO:0000299) |
0.0 | 0.2 | GO:0030057 | desmosome(GO:0030057) |
0.0 | 3.3 | GO:0005783 | endoplasmic reticulum(GO:0005783) |
0.0 | 0.0 | GO:0031143 | pseudopodium(GO:0031143) |
0.0 | 0.0 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
0.0 | 3.7 | GO:0000139 | Golgi membrane(GO:0000139) |
0.0 | 0.0 | GO:0070695 | FHF complex(GO:0070695) |
0.0 | 0.0 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
0.0 | 1.1 | GO:0048471 | perinuclear region of cytoplasm(GO:0048471) |
0.0 | 59.1 | GO:0016021 | integral component of membrane(GO:0016021) |
0.0 | 0.0 | GO:0072372 | primary cilium(GO:0072372) |
0.0 | 0.2 | GO:0005624 | obsolete membrane fraction(GO:0005624) |
0.0 | 0.1 | GO:0032982 | myosin filament(GO:0032982) |
0.0 | 0.1 | GO:0005768 | endosome(GO:0005768) |
0.0 | 21.3 | GO:0005622 | intracellular(GO:0005622) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.8 | 2.5 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
0.6 | 3.5 | GO:0016494 | C-X-C chemokine receptor activity(GO:0016494) |
0.6 | 1.7 | GO:0035184 | histone threonine kinase activity(GO:0035184) |
0.5 | 1.6 | GO:0046935 | 1-phosphatidylinositol-3-kinase regulator activity(GO:0046935) |
0.5 | 1.4 | GO:0030375 | thyroid hormone receptor coactivator activity(GO:0030375) |
0.4 | 5.2 | GO:0004697 | protein kinase C activity(GO:0004697) |
0.4 | 1.6 | GO:0030284 | estrogen receptor activity(GO:0030284) |
0.4 | 1.9 | GO:0034452 | dynactin binding(GO:0034452) |
0.4 | 1.1 | GO:0005113 | patched binding(GO:0005113) |
0.4 | 1.1 | GO:0004911 | interleukin-2 receptor activity(GO:0004911) |
0.4 | 1.8 | GO:0005131 | growth hormone receptor binding(GO:0005131) |
0.3 | 0.7 | GO:0032947 | protein complex scaffold(GO:0032947) |
0.3 | 0.3 | GO:0098531 | RNA polymerase II transcription factor activity, ligand-activated sequence-specific DNA binding(GO:0004879) transcription factor activity, direct ligand regulated sequence-specific DNA binding(GO:0098531) |
0.3 | 2.3 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
0.3 | 1.3 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
0.3 | 1.0 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
0.3 | 1.6 | GO:0052813 | phosphatidylinositol-4,5-bisphosphate 3-kinase activity(GO:0046934) phosphatidylinositol bisphosphate kinase activity(GO:0052813) |
0.3 | 0.9 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
0.3 | 0.9 | GO:0008545 | JUN kinase kinase activity(GO:0008545) |
0.3 | 0.9 | GO:0016151 | nickel cation binding(GO:0016151) |
0.3 | 0.9 | GO:0008109 | N-acetyllactosaminide beta-1,6-N-acetylglucosaminyltransferase activity(GO:0008109) |
0.3 | 1.9 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
0.3 | 3.9 | GO:0030159 | receptor signaling complex scaffold activity(GO:0030159) |
0.3 | 0.8 | GO:0000339 | RNA cap binding(GO:0000339) |
0.3 | 0.8 | GO:0050265 | RNA uridylyltransferase activity(GO:0050265) |
0.3 | 2.3 | GO:0034593 | phosphatidylinositol bisphosphate phosphatase activity(GO:0034593) |
0.3 | 1.3 | GO:0043422 | protein kinase B binding(GO:0043422) |
0.3 | 0.8 | GO:0043142 | single-stranded DNA-dependent ATPase activity(GO:0043142) |
0.2 | 0.7 | GO:0005049 | nuclear export signal receptor activity(GO:0005049) |
0.2 | 0.5 | GO:0035173 | histone kinase activity(GO:0035173) |
0.2 | 0.7 | GO:0004465 | lipoprotein lipase activity(GO:0004465) |
0.2 | 1.0 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
0.2 | 0.7 | GO:0043175 | RNA polymerase core enzyme binding(GO:0043175) |
0.2 | 0.7 | GO:0034236 | protein kinase A catalytic subunit binding(GO:0034236) |
0.2 | 0.7 | GO:0004527 | exonuclease activity(GO:0004527) |
0.2 | 0.7 | GO:0033691 | sialic acid binding(GO:0033691) |
0.2 | 0.2 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
0.2 | 0.7 | GO:0016312 | inositol bisphosphate phosphatase activity(GO:0016312) |
0.2 | 0.7 | GO:0033300 | dehydroascorbic acid transporter activity(GO:0033300) |
0.2 | 0.4 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
0.2 | 1.5 | GO:0032452 | histone demethylase activity(GO:0032452) |
0.2 | 5.0 | GO:0045028 | G-protein coupled nucleotide receptor activity(GO:0001608) G-protein coupled purinergic nucleotide receptor activity(GO:0045028) |
0.2 | 1.3 | GO:0050733 | RS domain binding(GO:0050733) |
0.2 | 0.6 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
0.2 | 1.2 | GO:0070087 | chromo shadow domain binding(GO:0070087) |
0.2 | 0.2 | GO:0042156 | obsolete zinc-mediated transcriptional activator activity(GO:0042156) |
0.2 | 0.6 | GO:0004311 | farnesyltranstransferase activity(GO:0004311) |
0.2 | 1.6 | GO:0004571 | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity(GO:0004571) |
0.2 | 1.0 | GO:0004046 | aminoacylase activity(GO:0004046) |
0.2 | 2.7 | GO:0031593 | polyubiquitin binding(GO:0031593) |
0.2 | 0.9 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
0.2 | 1.9 | GO:0016493 | C-C chemokine receptor activity(GO:0016493) |
0.2 | 0.6 | GO:0019863 | IgE binding(GO:0019863) |
0.2 | 0.9 | GO:0048156 | tau protein binding(GO:0048156) |
0.2 | 0.7 | GO:0004062 | aryl sulfotransferase activity(GO:0004062) |
0.2 | 0.7 | GO:0004064 | arylesterase activity(GO:0004064) |
0.2 | 0.6 | GO:0016362 | activin receptor activity, type II(GO:0016362) |
0.2 | 0.5 | GO:0004476 | mannose-6-phosphate isomerase activity(GO:0004476) |
0.2 | 0.7 | GO:0003720 | telomerase activity(GO:0003720) RNA-directed DNA polymerase activity(GO:0003964) |
0.2 | 0.7 | GO:0004301 | epoxide hydrolase activity(GO:0004301) |
0.2 | 2.3 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
0.2 | 1.4 | GO:0050700 | CARD domain binding(GO:0050700) |
0.2 | 2.6 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
0.2 | 0.5 | GO:0016774 | phosphotransferase activity, carboxyl group as acceptor(GO:0016774) |
0.2 | 0.3 | GO:0070273 | phosphatidylinositol-4-phosphate binding(GO:0070273) |
0.2 | 0.7 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
0.2 | 0.7 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
0.2 | 0.7 | GO:0004957 | prostaglandin E receptor activity(GO:0004957) |
0.2 | 1.0 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
0.2 | 0.5 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
0.2 | 2.0 | GO:0070403 | NAD+ binding(GO:0070403) |
0.2 | 0.8 | GO:0043539 | protein serine/threonine kinase activator activity(GO:0043539) |
0.2 | 1.5 | GO:0017025 | TBP-class protein binding(GO:0017025) |
0.2 | 0.5 | GO:0070569 | uridylyltransferase activity(GO:0070569) |
0.2 | 0.8 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
0.2 | 0.9 | GO:0015165 | pyrimidine nucleotide-sugar transmembrane transporter activity(GO:0015165) |
0.2 | 7.7 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
0.2 | 0.8 | GO:0004904 | interferon receptor activity(GO:0004904) |
0.2 | 0.6 | GO:0008379 | thioredoxin peroxidase activity(GO:0008379) |
0.2 | 0.6 | GO:0004791 | thioredoxin-disulfide reductase activity(GO:0004791) |
0.2 | 0.2 | GO:0000739 | obsolete DNA strand annealing activity(GO:0000739) |
0.2 | 0.3 | GO:0016842 | amidine-lyase activity(GO:0016842) |
0.2 | 0.5 | GO:0015038 | glutathione disulfide oxidoreductase activity(GO:0015038) |
0.2 | 0.6 | GO:0003917 | DNA topoisomerase type I activity(GO:0003917) |
0.2 | 1.2 | GO:0008536 | Ran GTPase binding(GO:0008536) |
0.2 | 0.5 | GO:0004677 | DNA-dependent protein kinase activity(GO:0004677) |
0.1 | 0.3 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
0.1 | 1.9 | GO:0017017 | MAP kinase tyrosine/serine/threonine phosphatase activity(GO:0017017) |
0.1 | 1.2 | GO:0016922 | ligand-dependent nuclear receptor binding(GO:0016922) |
0.1 | 0.9 | GO:0061133 | endopeptidase activator activity(GO:0061133) |
0.1 | 0.4 | GO:0070643 | vitamin D3 25-hydroxylase activity(GO:0030343) vitamin D 25-hydroxylase activity(GO:0070643) |
0.1 | 0.1 | GO:0035197 | siRNA binding(GO:0035197) |
0.1 | 1.5 | GO:0016854 | racemase and epimerase activity(GO:0016854) |
0.1 | 0.3 | GO:0008330 | protein tyrosine/threonine phosphatase activity(GO:0008330) |
0.1 | 0.3 | GO:0016896 | exoribonuclease activity, producing 5'-phosphomonoesters(GO:0016896) |
0.1 | 0.4 | GO:0070996 | type 1 melanocortin receptor binding(GO:0070996) |
0.1 | 2.6 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
0.1 | 0.1 | GO:0008432 | JUN kinase binding(GO:0008432) |
0.1 | 0.6 | GO:0015925 | galactosidase activity(GO:0015925) |
0.1 | 0.7 | GO:0009374 | biotin binding(GO:0009374) |
0.1 | 0.4 | GO:0004828 | serine-tRNA ligase activity(GO:0004828) |
0.1 | 0.9 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
0.1 | 0.4 | GO:0015272 | ATP-activated inward rectifier potassium channel activity(GO:0015272) |
0.1 | 1.0 | GO:0016274 | arginine N-methyltransferase activity(GO:0016273) protein-arginine N-methyltransferase activity(GO:0016274) |
0.1 | 0.6 | GO:0036002 | pre-mRNA binding(GO:0036002) |
0.1 | 0.6 | GO:0034713 | type I transforming growth factor beta receptor binding(GO:0034713) |
0.1 | 1.0 | GO:0008494 | translation activator activity(GO:0008494) |
0.1 | 0.8 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
0.1 | 0.1 | GO:0015440 | peptide-transporting ATPase activity(GO:0015440) |
0.1 | 0.9 | GO:0030332 | cyclin binding(GO:0030332) |
0.1 | 0.1 | GO:0004559 | alpha-mannosidase activity(GO:0004559) |
0.1 | 2.5 | GO:0008601 | protein phosphatase type 2A regulator activity(GO:0008601) |
0.1 | 1.2 | GO:0004579 | dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
0.1 | 0.4 | GO:0051733 | ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity(GO:0046404) polydeoxyribonucleotide kinase activity(GO:0051733) ATP-dependent polynucleotide kinase activity(GO:0051734) |
0.1 | 0.4 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
0.1 | 1.0 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
0.1 | 0.3 | GO:0008242 | omega peptidase activity(GO:0008242) |
0.1 | 0.8 | GO:0001784 | phosphotyrosine binding(GO:0001784) |
0.1 | 1.7 | GO:0005344 | oxygen transporter activity(GO:0005344) |
0.1 | 0.3 | GO:0051380 | norepinephrine binding(GO:0051380) |
0.1 | 0.8 | GO:0000014 | single-stranded DNA endodeoxyribonuclease activity(GO:0000014) |
0.1 | 0.5 | GO:0047238 | glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity(GO:0047238) |
0.1 | 1.4 | GO:0004861 | cyclin-dependent protein serine/threonine kinase inhibitor activity(GO:0004861) |
0.1 | 0.4 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
0.1 | 0.6 | GO:0016423 | tRNA (guanine) methyltransferase activity(GO:0016423) |
0.1 | 0.1 | GO:0050510 | N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity(GO:0050510) |
0.1 | 0.6 | GO:0000036 | ACP phosphopantetheine attachment site binding involved in fatty acid biosynthetic process(GO:0000036) ACP phosphopantetheine attachment site binding(GO:0044620) prosthetic group binding(GO:0051192) |
0.1 | 0.4 | GO:0047756 | chondroitin 4-sulfotransferase activity(GO:0047756) |
0.1 | 0.5 | GO:0060229 | lipase activator activity(GO:0060229) |
0.1 | 0.8 | GO:0016778 | diphosphotransferase activity(GO:0016778) |
0.1 | 1.8 | GO:0008373 | sialyltransferase activity(GO:0008373) |
0.1 | 0.1 | GO:0019958 | C-X-C chemokine binding(GO:0019958) interleukin-8 binding(GO:0019959) |
0.1 | 0.4 | GO:0000064 | L-ornithine transmembrane transporter activity(GO:0000064) |
0.1 | 0.7 | GO:0034235 | GPI anchor binding(GO:0034235) |
0.1 | 0.5 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
0.1 | 1.7 | GO:0005246 | calcium channel regulator activity(GO:0005246) |
0.1 | 0.4 | GO:0070548 | L-glutamine aminotransferase activity(GO:0070548) |
0.1 | 0.4 | GO:0004735 | pyrroline-5-carboxylate reductase activity(GO:0004735) |
0.1 | 0.5 | GO:0003960 | NADPH:quinone reductase activity(GO:0003960) |
0.1 | 0.4 | GO:0004013 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
0.1 | 2.9 | GO:0019843 | rRNA binding(GO:0019843) |
0.1 | 3.1 | GO:0004003 | ATP-dependent DNA helicase activity(GO:0004003) |
0.1 | 0.6 | GO:0045502 | dynein binding(GO:0045502) |
0.1 | 3.6 | GO:0003725 | double-stranded RNA binding(GO:0003725) |
0.1 | 0.4 | GO:0008821 | crossover junction endodeoxyribonuclease activity(GO:0008821) |
0.1 | 0.4 | GO:0016208 | AMP binding(GO:0016208) |
0.1 | 4.3 | GO:0004843 | thiol-dependent ubiquitin-specific protease activity(GO:0004843) thiol-dependent ubiquitinyl hydrolase activity(GO:0036459) ubiquitinyl hydrolase activity(GO:0101005) |
0.1 | 1.7 | GO:0019534 | toxin transporter activity(GO:0019534) |
0.1 | 0.7 | GO:0051400 | BH domain binding(GO:0051400) |
0.1 | 1.3 | GO:0046875 | ephrin receptor binding(GO:0046875) |
0.1 | 0.4 | GO:0003876 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
0.1 | 0.1 | GO:0032139 | dinucleotide insertion or deletion binding(GO:0032139) |
0.1 | 0.4 | GO:0004875 | complement receptor activity(GO:0004875) |
0.1 | 0.1 | GO:0051731 | polynucleotide 5'-hydroxyl-kinase activity(GO:0051731) |
0.1 | 0.4 | GO:0008898 | S-adenosylmethionine-homocysteine S-methyltransferase activity(GO:0008898) |
0.1 | 0.9 | GO:0008553 | hydrogen-exporting ATPase activity, phosphorylative mechanism(GO:0008553) |
0.1 | 2.3 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
0.1 | 0.6 | GO:0003997 | acyl-CoA oxidase activity(GO:0003997) |
0.1 | 3.9 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
0.1 | 0.2 | GO:0042166 | acetylcholine binding(GO:0042166) |
0.1 | 0.9 | GO:0001671 | ATPase activator activity(GO:0001671) |
0.1 | 0.5 | GO:0019788 | NEDD8 transferase activity(GO:0019788) |
0.1 | 0.3 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
0.1 | 1.4 | GO:0004065 | arylsulfatase activity(GO:0004065) |
0.1 | 0.3 | GO:0061731 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor(GO:0004748) oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor(GO:0016728) ribonucleoside-diphosphate reductase activity(GO:0061731) |
0.1 | 4.0 | GO:0008137 | NADH dehydrogenase activity(GO:0003954) NADH dehydrogenase (ubiquinone) activity(GO:0008137) NADH dehydrogenase (quinone) activity(GO:0050136) |
0.1 | 0.8 | GO:0051766 | inositol-1,4,5-trisphosphate 3-kinase activity(GO:0008440) inositol trisphosphate kinase activity(GO:0051766) |
0.1 | 1.0 | GO:0048531 | beta-1,3-galactosyltransferase activity(GO:0048531) |
0.1 | 0.3 | GO:0005338 | nucleotide-sugar transmembrane transporter activity(GO:0005338) |
0.1 | 0.4 | GO:0004083 | bisphosphoglycerate mutase activity(GO:0004082) bisphosphoglycerate 2-phosphatase activity(GO:0004083) phosphoglycerate mutase activity(GO:0004619) |
0.1 | 0.2 | GO:0015924 | mannosyl-oligosaccharide mannosidase activity(GO:0015924) |
0.1 | 0.7 | GO:0008079 | translation release factor activity(GO:0003747) translation termination factor activity(GO:0008079) |
0.1 | 0.8 | GO:0015278 | calcium-release channel activity(GO:0015278) ligand-gated calcium channel activity(GO:0099604) |
0.1 | 0.3 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
0.1 | 0.3 | GO:0034237 | protein kinase A regulatory subunit binding(GO:0034237) |
0.1 | 0.2 | GO:0016408 | C-acyltransferase activity(GO:0016408) |
0.1 | 0.7 | GO:0019789 | SUMO transferase activity(GO:0019789) |
0.1 | 0.7 | GO:0051018 | protein kinase A binding(GO:0051018) |
0.1 | 1.2 | GO:0070411 | I-SMAD binding(GO:0070411) |
0.1 | 0.4 | GO:0016504 | peptidase activator activity(GO:0016504) |
0.1 | 0.3 | GO:0004351 | glutamate decarboxylase activity(GO:0004351) |
0.1 | 1.1 | GO:0051879 | Hsp90 protein binding(GO:0051879) |
0.1 | 0.5 | GO:0042392 | sphingosine-1-phosphate phosphatase activity(GO:0042392) |
0.1 | 1.0 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
0.1 | 0.4 | GO:0004774 | succinate-CoA ligase activity(GO:0004774) |
0.1 | 1.0 | GO:0003709 | obsolete RNA polymerase III transcription factor activity(GO:0003709) |
0.1 | 0.3 | GO:0016882 | cyclo-ligase activity(GO:0016882) |
0.1 | 0.2 | GO:0004505 | phenylalanine 4-monooxygenase activity(GO:0004505) |
0.1 | 0.4 | GO:0008172 | S-methyltransferase activity(GO:0008172) |
0.1 | 0.5 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
0.1 | 0.4 | GO:0045309 | protein phosphorylated amino acid binding(GO:0045309) |
0.1 | 2.0 | GO:0004864 | protein phosphatase inhibitor activity(GO:0004864) |
0.1 | 0.3 | GO:0016509 | long-chain-3-hydroxyacyl-CoA dehydrogenase activity(GO:0016509) |
0.1 | 0.6 | GO:0001727 | lipid kinase activity(GO:0001727) |
0.1 | 1.6 | GO:0051059 | NF-kappaB binding(GO:0051059) |
0.1 | 1.2 | GO:0008556 | potassium-transporting ATPase activity(GO:0008556) |
0.1 | 1.7 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.1 | 0.3 | GO:0031435 | mitogen-activated protein kinase kinase kinase binding(GO:0031435) |
0.1 | 0.3 | GO:0043047 | single-stranded telomeric DNA binding(GO:0043047) sequence-specific single stranded DNA binding(GO:0098847) |
0.1 | 1.5 | GO:0016892 | endoribonuclease activity, producing 3'-phosphomonoesters(GO:0016892) |
0.1 | 0.4 | GO:0008649 | rRNA methyltransferase activity(GO:0008649) |
0.1 | 0.6 | GO:0008266 | poly(U) RNA binding(GO:0008266) |
0.1 | 0.9 | GO:0035251 | UDP-glucosyltransferase activity(GO:0035251) |
0.1 | 1.3 | GO:0043022 | ribosome binding(GO:0043022) |
0.1 | 0.3 | GO:0043515 | kinetochore binding(GO:0043515) |
0.1 | 0.4 | GO:0004596 | peptide alpha-N-acetyltransferase activity(GO:0004596) |
0.1 | 1.9 | GO:0070003 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
0.1 | 1.2 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
0.1 | 4.7 | GO:0004197 | cysteine-type endopeptidase activity(GO:0004197) |
0.1 | 0.4 | GO:0005030 | neurotrophin receptor activity(GO:0005030) |
0.1 | 0.6 | GO:0004457 | lactate dehydrogenase activity(GO:0004457) |
0.1 | 0.3 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
0.1 | 0.7 | GO:0003785 | actin monomer binding(GO:0003785) |
0.1 | 0.3 | GO:0019166 | trans-2-enoyl-CoA reductase (NADPH) activity(GO:0019166) |
0.1 | 0.3 | GO:0098599 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
0.1 | 0.3 | GO:0019992 | diacylglycerol binding(GO:0019992) |
0.1 | 0.5 | GO:0015355 | secondary active monocarboxylate transmembrane transporter activity(GO:0015355) |
0.1 | 0.4 | GO:0004974 | leukotriene receptor activity(GO:0004974) |
0.1 | 0.6 | GO:0050786 | RAGE receptor binding(GO:0050786) |
0.1 | 0.2 | GO:0031685 | adenosine receptor binding(GO:0031685) |
0.1 | 0.4 | GO:0004656 | procollagen-proline 4-dioxygenase activity(GO:0004656) peptidyl-proline 4-dioxygenase activity(GO:0031545) |
0.1 | 0.2 | GO:0000405 | bubble DNA binding(GO:0000405) |
0.1 | 0.3 | GO:0004897 | ciliary neurotrophic factor receptor activity(GO:0004897) |
0.1 | 1.2 | GO:0005547 | phosphatidylinositol-3,4,5-trisphosphate binding(GO:0005547) |
0.1 | 0.3 | GO:0071723 | lipopeptide binding(GO:0071723) |
0.1 | 0.4 | GO:0015252 | hydrogen ion channel activity(GO:0015252) |
0.1 | 0.2 | GO:0017159 | pantetheine hydrolase activity(GO:0017159) |
0.1 | 0.4 | GO:0031013 | troponin I binding(GO:0031013) |
0.1 | 0.3 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
0.1 | 1.9 | GO:0019829 | cation-transporting ATPase activity(GO:0019829) |
0.1 | 0.3 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
0.1 | 0.3 | GO:0051787 | misfolded protein binding(GO:0051787) |
0.1 | 0.3 | GO:0004591 | oxoglutarate dehydrogenase (succinyl-transferring) activity(GO:0004591) |
0.1 | 0.3 | GO:0050681 | androgen receptor binding(GO:0050681) |
0.1 | 0.5 | GO:0004331 | fructose-2,6-bisphosphate 2-phosphatase activity(GO:0004331) |
0.1 | 0.9 | GO:0042288 | MHC class I protein binding(GO:0042288) |
0.1 | 0.3 | GO:0005087 | Ran guanyl-nucleotide exchange factor activity(GO:0005087) |
0.1 | 0.9 | GO:0003756 | protein disulfide isomerase activity(GO:0003756) intramolecular oxidoreductase activity, transposing S-S bonds(GO:0016864) |
0.1 | 1.9 | GO:0003823 | antigen binding(GO:0003823) |
0.1 | 1.3 | GO:0035064 | methylated histone binding(GO:0035064) |
0.1 | 0.2 | GO:0032451 | demethylase activity(GO:0032451) |
0.1 | 0.8 | GO:0016884 | carbon-nitrogen ligase activity, with glutamine as amido-N-donor(GO:0016884) |
0.1 | 0.2 | GO:0070215 | obsolete MDM2 binding(GO:0070215) |
0.1 | 0.3 | GO:0004829 | threonine-tRNA ligase activity(GO:0004829) |
0.1 | 0.4 | GO:0003847 | 1-alkyl-2-acetylglycerophosphocholine esterase activity(GO:0003847) |
0.1 | 0.2 | GO:0043008 | ATP-dependent protein binding(GO:0043008) |
0.1 | 0.4 | GO:0016833 | oxo-acid-lyase activity(GO:0016833) |
0.1 | 0.4 | GO:0001595 | angiotensin receptor activity(GO:0001595) angiotensin type II receptor activity(GO:0004945) |
0.1 | 0.2 | GO:0030292 | protein tyrosine kinase inhibitor activity(GO:0030292) |
0.1 | 0.7 | GO:0003906 | DNA-(apurinic or apyrimidinic site) lyase activity(GO:0003906) |
0.1 | 5.7 | GO:0008135 | translation factor activity, RNA binding(GO:0008135) |
0.1 |